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CHAPTER 1 
INTRODUCTION 
 
 
 
 
1.1 BACKGROUND:
1
 HOMOGENEOUS 
ENANTIOSELECTIVE CATALYSIS 
 
 
Chirality is all over around you: it‟s with you when you go to work, when 
you pay your taxes, when you write on a computer, like I‟m doing, with a 
chiral object: your hand!!!. The fascinating chemistry of life is based 
upon asymmetric interactions, which occur through chiral recognition. 
Hence, a wide number of biologically active molecules, such as 
aminoacids, carbohydrates and vitamins, exists as a single enantiomer. 
The same concept holds true for important manufactured products, such 
as pharmaceuticals, agrochemicals, flavours and fragrances. Since only 
one enantiomer has the desired 
biological property, recent 
regulations demand the 
production of the only active 
enantiomer, strongly 
disfavouring 
commercialisation of racemates. Four general approaches (Fig. 1) are 
commonly pursued for producing enantiopure compounds, and all of 
them are based upon the consideration that chiral compounds can be 
artificially produced only in the presence of another chiral agent
1
 (see 
                                                 
1
 Blaser, H. U.; Pugin B.; Splinder F. Journal of Molecular Catalysis A: Chemical 231 2005 1–20 
Progress in enantioselective catalysis assessed from an industrial point of view. 
 4 
Table 1.1 for a comparison of the different methodologies and an 
assessment concerning their suitability for industrial applications).
2
 
   
 
Table 1.1 
 
 
While crystallisation of diastereomeric adducts can be applied on any 
scale, separation via HPLC is probably most important in the early phase 
of product development and is restricted to small-scale (100 kg to tonnes), 
high-value products. In both cases, large amounts of solvents have to be 
handled and of course at least 50% of the material with the wrong 
absolute configuration has to be either recycled or discarded. 
The chiral pool approach uses chiral building blocks originating from 
natural products for the construction of the final molecule. This approach 
is very often chosen in the early phases of drug development but, 
depending on the commercial availability of the starting material, it can 
also be used for large-scale products. Because natural products very often 
have high enantiomeric purity, no further enrichment is usually necessary.  
Enantioselective syntheses are performed with the help of covalently 
bound chiral auxiliaries, often from the chiral pool. These are not 
incorporated in the target molecule but are removed after the stereogenic 
centres have been established, and must be either recycled or discarded. 
                                                 
2
    J. Crosby, in: A.N. Collins, G.N. Sheldrake, J. Crosby (Eds.), Chirality in Industry I, John Wiley, 
Chichester, 1992, p. 1.   
 
 5 
In many respects the most elegant approach is enantioselective catalysis 
where prochiral starting materials are transformed to enantioenriched 
products with the help of chiral catalysts. Effective catalysts are either 
synthetic (chemocatalysis) or can be of natural origin (biocatalysis). An 
important issue is often the time needed to find and to develop an efficient 
biocatalyst, especially when the starting material is not a very close 
analogue to the natural substrate. In addition, product isolation can be a 
serious problem since reactions are often carried out in a rather dilute 
aqueous solution. But as several recent publications convincingly show,
3
 
these hurdle can be overcome. 
Over the years, three types of enantioselective chemocatalysts have 
proven to be synthetically useful. The most versatile ones are 
homogeneous metal complexes containing ligands with a chiral backbone 
carrying one or more coordinating heteroatoms. For noble metals, 
especially Rh, Pd, Ru, Ir and Os these are tertiary P or N atoms, for 
metals such as Ti, B, Zn, Co, Mn or Cu ligands with coordinating O or N 
atoms are usually preferred. This methodology has just received its due 
recognition in the 2001 Nobel Prize to W.S. Knowles and R. Noyori for 
enantioselective hydrogenation and to K.B. Sharpless for enantioselective 
oxidation catalysis.
4
 Also useful for synthetic application are 
heterogeneous metallic catalysts, modified with chiral auxiliaries
5
 and 
finally organocatalysis, i.e. the use of chiral soluble organic bases and 
acids is at the moment a very hot research topic with quite a lot promise 
for future industrial applications.
6
 While most applications are in the field 
of asymmetric synthesis starting from a prochiral substrate, kinetic 
                                                 
3
 (a) H.U. Blaser, E. Schmidt (Eds.), Large Scale Asymmetric Catalysis, Wiley-VCH, Weinheim, 
2003, p.1; (b) W.S. Knowles, in: H.U. Blaser, E. Schmidt (Eds.), Large Scale Asymmetric Catalysis, 
Wiley-VCH, Weinheim, 2003, p. 23; (c) A.J.J. Straathof, S. Panke, A. Schmid, Curr. Opinion 
Biotechnol. 13; 2002; 548. 
4
 For details see Nobel Lectures, Angew. Chem. Int. Ed. 41; 2002; 1998–2022. 
5
 M. Studer, H.U. Blaser, C. Exner, Adv. Synth. Catal. 345; 2003; 45. 
6
 see K.N. Houk, B. List, Acc. Chem. Res. 37; 2004; 487 
 6 
resolution, i.e., the preferential transformation of one enantiomer of a 
racemic substrate, is of growing synthetic importance.
7
  
Up to now, relatively few enantioselective catalysts are used on an 
industrial scale. One reason is that enantioselective catalysis is a relatively 
young discipline, but at the same time it is a rapidly expanding field. Up 
to 1985, only few catalysts affording enantioselectivities of more than 
90% were known.
8
 This has changed dramatically in recent years and 
there are now a large number of chiral catalysts able to catalyze a variety 
of transformation with ees >98%.
9
 Some example of industrial application 
of enantioselective catalyst are the Monsanto L-DOPA process
7
 and 
Jacobsen‟s hydrolytic kinetic resolution (HKR) of epichlorohydrin.10 
Anyway, the application of homogeneous enantioselective catalysts on a 
technical scale presents some other special challenges and problems. 
Some of these problems are due to the special manufacturing situation of 
the products involved (small scale-high added values product, 
development time, etc.). Others Problems are due to the nature of the 
enantioselective catalytic processes. A major challenge which still 
remains is the transfer of the results obtained for a particular substrate to 
even a close analog due to the low tolerance for structure variation even 
within a class of substrates (substrate specificity). The industrial 
application of enantioselective catalysts is also hampered by a lack of 
information on their synthetic scope and limitations. In addition, catalyst 
activities or productivities are often not given for new catalysts (in the 
                                                 
7
(a) J.M. Keith, J.F. Larrow, E.N. Jacobsen, Adv. Synth. Catal. 343; 2001; 5; (b) D.E.J.E. Robinson, 
S.D. Bull, Tetrahedron: Asymmetry; 2003; 14 1407. 
8
 J.D. Morrison (Ed.), Asymmetric Synthesis, vol. 5, Academic Press, New York, 1985. 
9
 (a) For an exhaustive review on this topic, see:  E. N. Jacobsen, A. Pfaltz and H. Yamamoto (Eds.), 
Comprehensive Asymmetric Catalysis, Springer, Berlin, 1999, and references cited in the reviews. 
(b) For an exhaustive review on this topic, see: T. Ohkuma, M. Kitamura, R. Noyori, in: I. Ojima 
(Ed.), Catalytic Asymmetric Synthesis, second ed., Wiley-VCH, Weinheim, 2000 and references cited 
in these reviews. 
10
 (a) Schaus S.E., Brandes B. D.,. Larrow J. F., Tokunaga M., Hansen K. B., Gould A. E., Furrow 
M. E., Jacobsen E. N., J. Am. Chem. Soc. 2002, 124, 1307. 
(b) for a list of chiral building blocks available via the HKR chemistry, see: www.rhodia.com 
 7 
literature enantioselectivity is still the dominant criterion) and 
applications to the synthesis of “real” substrates are rather scarce (usually 
simple model reaction are studied). Finally, many chiral ligands and metal 
precursors are expensive and/or not easily available in technical 
quantities.. Over the years, homogeneous chemo-catalysts based on metal 
centres tailored with suitable chiral ligands have attracted increasing 
academic and industrial interest because relevant reactionparameters, such 
as activity, selectivity and catalyst life can often be rationally optimised 
Therefore, homogeneous enantioselective catalysis is today a fundamental 
technology for the production of fine chemicals.
 11
 
Enantiomerically enriched compounds produced in this way are typically 
used as pharmaceuticals and vitamins,
12
 agrochemicals
4
 and flavors and 
fragrances. Other applications are functional materials such as chiral 
polymers, materials with non-linear optical properties or ferroelectric 
liquid crystals. For many applications of such chiral compounds, the 
racemic forms will no longer be accepted.
13
 As a consequence, the 
importance of enantioselective synthesis in general, and of 
enantioselective catalysis in particular, has increased. 
 As a consequence of the peculiarities of enantioselective catalysis 
described above, the following critical factors often determine the 
viability of an enantioselective process: 
 
 The enantioselectivity, expressed as enantiomeric excess (% ee), i.e., % 
desired−% undesired enantiomer. The ee of a catalyst should be >99% for 
pharmaceuticals if no purification is possible (via recrystallization or at a 
later stage via separation of diastereomeric intermediates). This case is 
                                                 
11
 Blaser, H. U.; Schmidt, E. Asymmetric Catalysis on Industrial Scale, 1st ed.; Wiley-VCH: Weinheim, 
Germany, 2004. 
12
 For a recent update on chiral pharmaceuticals see A.M. Rouhi, C&EN, June 14, 2004, p. 47. 
 8 
quite rare and ees >90% are often acceptable; for agrochemicals ees 
>80% can be sufficient.  
 The chemoselectivity and/or functional group tolerance will be very 
important when multifunctional substrates are involved. 
 The catalyst productivity, given as turnover number (TON), determines 
catalyst costs. TONs ought to be >1000 for small scale, high value 
products and >50,000 for large scale or less expensive products (catalyst 
re-use increases the productivity). 
 The catalyst activity, given as turnover frequency for >95% conversion 
(TOF, h−
1
), determines the production capacity. For hydrogenations, 
TOFs ought to be >500 h−
1
 for small scale and >10,000 h−1 for large 
scale products. 
 Availability and cost of ligands. In the majority of cases these are chiral 
diphosphines that need special synthetic know how and can be rather 
expensive. Typical prices are 100–500 $/g for laboratory quantities and 
5000 to >20,000 $/kg on a larger scale. Chiral ligands such as diamines or 
amino alcohols used for early transition metals are usually cheaper. 
 Intellectual property. Many chiral ligands and/or catalysts are patent 
protected. It is essential to obtain the right to use proprietary catalysts on 
a commercial basis at reasonable costs and conditions. 
 Availability and cost of starting materials. Starting materials are often 
expensive and difficult to manufacture on a large scale with the high 
purity required for catalytic reactions. 
 Development time. Can be crucial if an optimal ligand has to be 
developed for a particular substrate (substrate specificity) and when not 
                                                                                                                                            
13
 G.M. Ramos Tombo; H.U. Blaser, in: G.T. Brooks, T.R. Roberts (Eds.), Pesticide Chemistry and 
Bioscience, Royal Society of Chemistry, Cambridge, 1999, p. 33, and references cited therein. 
 9 
much know-how is available on the catalytic process (technological 
maturity). 
 
For most other aspects such as catalyst stability and sensitivity, handling 
problems, catalyst separation, space time yield, poisoning, process 
sensitivity, toxicity, safety, special equipment, etc., enantioselective 
catalysts have similar problems and requirements as nonchiral 
homogeneous catalysts. 
Which of these criteria will be critical for the development of a specific 
process depends on the specific catalyst and transformation (see Table 
1.2 for a comparison of the different industrial applications of 
enantioselective catalytic reaction). 
 
 
Table 1.2 
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1.2 CARBOHYDRATES AS BUILDING BLOCKS OF 
PRIVILEGED LIGANDS
14
  
 
Beside the choice of the active metal, the accurate design of the chiral 
ligand is crucial for its effective application. The ligand must possess a 
well-defined three-dimensional structure, capable of directing the 
stereochemistry of the reaction. Accordingly, in 2002 a few selected 
ligands of wide and proven applicability were indicated as „privileged‟ by 
Jacobsen
15
 (in brackets in Figure 2). Over the years, this original class of 
privileged ligands was gradually extended to include other effective 
structures, and in 2008, the Aldrich Chemical Company reviewed
16
 an 
entire class comprising more than 30 structures (in Figure 2). At the same 
time, several research groups demonstrated that highly performing ligands 
can be attained by simple modification of molecules from the natural 
chiral pool, such as carbohydrates.
17
 This strategy is based upon the 
assumption that sugars are both abundant (therefore easily available) and 
“naturally chiral”, which avoids the complicated resolution of racemates. 
Furthermore, carbohydrates are highly functionalised and their chemistry 
is extremely well developed. This latter feature is particularly attractive 
because modular ligands with similar structural motifs can be created, 
thus making possible the generation of libraries. 
 
 
 
                                                 
14
 For an exhaustive review on this topic, see: V. Benessere, A. De Roma, R Del Litto, F. Ruffo; 
Coordination Chemistry Reviews 254; 2010; 390–401 
15
 Yoon, T. P.; Jacobsen, E. N. Science 2003, 299, 1691. 
16
 ChemFiles, Asymmetric Catalysis, Privileged Ligands and Complexes, Vol. 8, Aldrich Chemical, 
2008 
17
 (a) D. Steinborn, H. Junicke, Chem. Rev. 100; 2000; 4283; (b) M. Dièguez, O. Pàmies, A. Ruiz, 
Y. Diaz, S. Castillòn, C. Claver, Coord. Chem. Rev. 248; 2004 2165; (c) M. Dièguez, O. Pàmies, C. 
Claver, Chem. Rev. 104; 2004; 3189; (d) Y. Diaz, S. Castillòn, C. Claver, Chem. Soc. Rev. 34; 2005; 
702; (e) M. Dièguez, C. Claver, O. Pàmies, Eur. J. Org. Chem.; 2007; 4621; (f) M.M.K. Boysen, 
Chem. Eur. J. 13; 2007; 8648; (g) M. Dièguez, O. Pàmies, Chem. Eur. J. 14; 2008; 944. 
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Figure 2: the privileged ligands 
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This strategy is expected to be especially productive when carbohydrates 
are used as building blocks of “privileged” ligands, aiming to amplify the 
scope of their application. The introduction of privileged moieties into a 
sugar backbone promises to afford unique ligand structures, which 
combine efficiency with convenience and flexibility. This was 
demonstrated on several occasions, and today many “privileged” ligands 
of Figure 2 do possess a corresponding sugar version.
14
 An additional 
benefit is that the generous presence of functional groups in sugars can be 
employed for “tagging” the “privileged” ligands in view of their 
application in multiphase homogeneous catalysis. This methodology 
allows easy catalyst re-cycling via simple phase separation, and relies on 
using two immiscible solvents and a phase-tagged catalysts, which are 
soluble in only one of the two solvents (catalyst phase), while being 
insoluble in the other solvent (reactant/product phase).
18
 
Given this premise, the research group where this thesis was carried out 
on focalized the last years activity in optimising the attainment of 
effective chiral ligands by simple derivatisation of common 
carbohydrates,
19
 for example, D-glucose. This successful approach,
20
 
developed in this thesis, produced the modular ligands‟ library 
naplephos, whose general structure is shown in Figure 3.  
 
 
 
                                                 
18
 See: B. Cornils,W.A. Herrmann, I.T. Horvarth,W. Leitner, S. Mecking, H. Olivier-Borbigou, D. 
Vogt (Eds.), multiphase Homogeneous Catalysis, 1st ed., Wiley-VCH,Weinheim, Germany, 2005. 
19
 Also other groups are active within this field of research. For reviews, see reference 14 and:  (a) 
Steinborn, D.; Junicke, H. Chem. Rev. 2000, 100, 4283; (b) Dièuez, M.; Pàmies, O.; Ruiz, A.; Diàz, 
Y.; Castillòn, S.; Claver, C. Coord. Chem. Rev. 2004, 248, 2165; (c) Dièguez, M.; Pàmies, O.; 
Claver, C. Chem. Rev. 2004, 104, 3189;  (d) Diàz, Y.; Castillòn, S.; Claver, C. Chem. Soc. Rev. 
2005, 34, 702;  (e) Dièguez, M.; Claver, C.; Pàmies, O. Eur. J. Org. Chem. 2007, 4621;  (f) Dièguez, 
M.; Pàmies, O. Chem. Eur. J. 2008, 944;   (g) Boysen, M. M. K. Chem. Eur. J. 2007, 13, 8648;  
20
 (a) Benessere, V.; Del Litto, R.; Ruffo, F.; Moberg, C. Eur. J. Org. Chem. 2009, 1352;  (b) De 
Roma, A.; Ruffo, F.; Woodward, S. Chem. Commun. 2008, 5, 384;  (c) Benessere, V.; De Roma, A.; 
Ruffo, F. ChemSusChem 2008, 1, 425. 
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This general structure combines the essential structural motifs of the Trost 
„privileged‟ ligands based on 1,2-trans-cyclohexanediamine16 with 
increased flexibility and accessibility (Figure 4).  
 
 
H2N NH2
cyclohexane-trans-1,2-diamine
H2N
NH2
 
 
NH HN
PP
OO
Ph2 Ph2
Trost ligands
NH HN
NP
OO
Ph2
 
Figure 4 
Position 1 shows a -benzyl (R‟= CH2Ph), of immediate and selective 
introduction. Positions 4 and 6, so far protected with a benzylidene ring, 
are potentially useful for phase-tagging the ligands and, hence, for 
defining the physical properties of the catalyst. Position 3 is instead useful 
for introducing tailored hindrance next to the metal centre. 
 14 
In fact, by proper choice of the R residue (Figure 5), the basic structure 
naplephos was already previously effectively adapted
20(b)(c)
 to two 
different  enantioselective processes, affording in all cases the chiral 
product in high ee‟s (reactions a and b in Scheme 1.1).  
 
 
 
 
 
 
 
 
 
Figure 5 
 
 
                                                                    
 
                                                                                                                                                                                              
(a) 
 
 
 
 
 
 
  
(b) 
 
 
 
 
Scheme 1.1 
 
During this thesis, a library of naplephos ligands was prepared, aiming to 
study its application in another relevant reaction: the Pd-catalyzed 
asymmetric allylic alkylation
21
 (AAA) depicted in Scheme 1.2. 
                                                 
21
 For reviews, see: (a) Tsuji, J. Palladium Reagents in Catalysis. In Innovation in Organic 
Synthesis; Wiley: New York, 1995;  (b) Trost, B. M.; Van Vranken, D. L. Chem. Rev. 1996, 96, 395;   
(c) Johannsen, M.; Jorgensen, A. Chem. Rev. 1998, 98, 1689;  (d) Pfaltz, A.; Lautens, M.. In 
Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer: 
Berlin, 1999; Vol. 2, Chapter 24;  (e) Trost, B. M.; Crawley, M. L. Chem. Rev. 2003, 103, 2921;  (f) 
450 Helmchen, G.; Pfaltz, A. Acc. Chem. Res. 2000, 33, 336;  (g) Lu, Z.; Ma, S. Angew. Chem., Int. 
Ed. 2008, 120, 258. 
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[Pd(C3H5)Cl]2, Ligand
Na[CH(CO2Me)2],
THF, RT
OAc CH(CO2Me)2
 
 
Scheme 1.2 
 
This reaction is commonly used in different synthetic procedures, because 
it allows the enantioselective formation of  carbon-carbon or carbon-
heteroatom bonds on different allylic substrates using a wide variety of 
nucleophiles and different metal. 
 
Moreover, in order to verify the further 
versatility of the structure and its aptitude to 
afford chiral ligands of broad and 
established applicability, bispyridylamides 
ligands (Figure. 6) based on D-glucose 
were examined in Mo-catalyzed AAA 
(Scheme 1.3) reactions during a period of work at the KTH in Sotckholm 
in Prof. C. Moberg‟s lab.  
                        
 
 
Scheme 1.3 
 
 
 
 
Catalyst re-cycle through conventional separation methods is often the 
major hinder to the industrial application of homogeneous catalysis.  
OCO2Me
OCO2Me
CO2MeMeO2C
CO2Me
CO2Me
4
(±)-5
6 7
Mo(CO)6, Ligand
CH2(CO2Me)2, BSA
THF, w, 160 C
6-15 min
+
 16 
Nowadays, the methodology of choice for solving this problem is the 
multiphasic homogeneous catalysis.
22
 This strategy requires 
heterogenization of the catalyst, through either its anchorage to a solid 
support or its selective immobilization in a liquid phase (e.g. RTIL) 
immiscible with the products phase. In these conditions, the catalyst is 
easily recycled at the end of the reaction by simple phase separation. 
Of course, this approach requires suitable tagging of the catalyst, because 
precise physical properties are necessary for its efficient heterogenization.  
To pave the way for further studies and to proof the possibility of 
performing multiphase catalysis with ligands based on carbohydrates, the 
last part of this thesis treated the preliminary synthesis and the application 
in ionic liquid Pd-catalyzed AAA of a new promising 4,6 phosphate 
based ligand class (Figure 7) that could show either a neutral or ionic 
behaviour. 
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Multiphase Homogeneous Catalysis, 1st ed.; Eds: B. Cornils, W.A. Herrmann, I.T. Horvarth, W. 
Leitner, S. Mecking, H. Olivier-Borbigou, D. Vogt, Wiley-VCH: Weinheim, Germany, 2005.
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CHAPTER 2 
RESULTS AND DISCUSSION 
 
 
 
 
2.1  LIGANDS DESIGN 
 
2.1.1  NAPLEPHOS BASED LIGANDS 
 
The distinctive structure of the naplephos ligands (Figure 8) is clearly 
defined, and is optimised for both synthetic convenience and catalytic 
performance (Scheme 1.2).  
 
O
O
O
O
OCH2Ph
HN
Ar
O
Ph2P
O
R
 
naplephos 
Figure 8 
 
Starting from inexpensive N-acetylglucosamine, C1 is selectively 
benzylated at the α-position ((i) in Scheme 2.1), thus avoiding a tedious 
separation of anomers. Positions 4 and 6 are protected with a 4-MeO-
benzylidene ring ((ii) in Scheme 2.1), which stabilises the chair 
conformation of the sugar ring, with possible consequent benefit for the 
outcome of the catalysis.
1
 At the same time, this protection can also be 
easily removed if a different functionalisation is desired.  
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Reagents and conditions: (i) BzOH, AcCl, reflux;  (ii) 4-MeO–C6H4–CHO, ZnCl2, 120°C; (iii) EtOH, 
KOH; (iv) Dry DCM, o-C6H4–PPh2–CO2H, N,N'-Dicyclohexylcarbodiimide (DCC), 4-
Dimethylaminopyridine (DMAP); See experimental section for details. 
Scheme 2.1 
 
Position -2 is then deprotected by a classical basic hydrolysis ((iii) in 
Scheme 2.1), then a rigid coordinating diphenylphosphinoamido arm is 
introduced by simple condensation with (2-diphenylphosphino)benzoic 
(or naftoic sometimes) acid ((iv) in Scheme 2.1). This reaction is 
selective towards the amino function due to its higher nucleophilicity, and 
introduces the essential coordinating feature of the “privileged” Trost 
                                                                                                                                            
1
 Benessere, V.; De Roma, A.; Ruffo, F. ChemSusChem 2008, 1, 425. 
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ligand
2
 in the molecule. In this step, DCC and DMAP activate the 
carboxylic group of the (2-diphenylphosphino)benzoic acid, according to 
the mechanism described below. The nucleophilic catalyst (DMAP) 
deprotonates the acid, increasing its  nucleophilicity, and hence its 
reactivity towards DCC (Scheme 2.2). 
 
R
C
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O
+
N
N
H3C CH3
R
C
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H
N
N
H3C CH3
R
C
O-
O
+ N C N N C N
C
O
OR
+
DMAP
DCC
-
 
Scheme 2.2 
 
The reaction intermediate is protonated by the DMAP cation present in 
solution, then the amino function attacks the carbonylic carbon, forming 
the amido group (Scheme 2.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
2
 ChemFiles, Asymmetric Catalysis, Privileged Ligands and Complexes, Vol. 8, Aldrich Chemical, 
2008. 
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The synthetic intermediate OP in Scheme 2.1 is the key intermediate for 
the syntesis of the whole ligands library. The last step is a condensation 
(with a mechanism analogue to that mentioned before) of a carboxylic 
acid on C3 (Scheme 2.4). The ester R group is the only variable ((v) in 
Scheme 2.4), and is chosen according to the type of catalytic reaction. As 
mentioned above, when R is again a diphenylphosphino function, the 
corresponding naplephos-a was already productively applied in both the 
Pd-catalysed desymmetrisation of meso-diols
1
 (ee up to 98%) and the Cu- 
catalysed addition of dialkylzinc to enones
3
 (ee up to 95%). 
 
 
 
 
 
 
 
 
                                                 
3
 (b) De Roma, A.; Ruffo, F.; Woodward, S. Chem. Commun. 2008, 5384; 
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(v)
OP intermediate
naplephos
a, R= o-C6H4-PPh2          
b, R= Me                         
c, R= CH2Ph                    
d, R= CH2Cy                   
e, R= t-Bu                       
f, R= (R)-CHEt(Ph)         
g, R= (S)-CHEt(Ph)
h, R= CHPh2 
i, R= CMePh2
j, R= CHCy2
k, R= Ph
l, R= CH2C6F5
m, R= CH2Ph(2,5
-bis-Me)
n, R= CH2Ph(3,5
-bis-Me)
o, R= o-Py                  o', R + naftoic in 2
p, R= o-Chinaldic        p', R + naftoic in 2
q, R= CH2NMe2
r, R= CH2NEt2
s, R= NMe2
t, R= NEt2
u, R= N(isoprop)2
v, R= N(But)2
O
OBn
NHO
O
O
O
PPh2
O
R
Ar
 
(v) Dry DCM, RCO2H, DCC, DMAP. See experimental section for details. 
Scheme 2.4 
 
We synthesyzed three sub-classes of ligands with different 
stereoelectronic feature: 
 R was selected among simple and readly available alkyl and aryl 
groups (b–n, see Scheme 2.4), with position 3 having just a steric 
control effect.
4
 
 R was selected among simple derivates of picolinic acid (o, o’, p, 
p’), with position 3 having a sp2 N atom with coordination 
capability. 
 R was selected among simple derivates of an aminoester, with 
position 3 having sp
3
 N atom with different stereoelectronic features 
(q-v). 
 
4
Benessere, V.; Ruffo, F. Tetrahedron Asymm., 2010, 21, 176.  
OP 
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Finally, after having recognized  naplephos-h as the most effective 
ligand in the asymmetric allylic alkylation (see section 2.3), a family 
of analogue ligands were prepared in order to enlighten effects due to 
the local inversion of configuration and to outline the effect of position 
1 on the catalytic activity (secondary stereochemical effect): these 
ligand had the following stereochemical feature: 
 
1. inverted groups at C2 and C3 (L1). 
2. Nap-h based on allose (L2).  
3. Nap-h with alfa-OMe group in position 1 to reduce the steric 
hindrance of this position (L3). 
 
The synthetic procedure for the ligand L1, compared to the synthesis of 
the analogue, just invert the order of the two condensation reactions 
(scheme 2.5). 
 
O
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O
HO
OCH2Ph
NH2
MeO
1
23
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56
O
O
O
HO
OCH2Ph
HN
O
MeO
1
23
4
56
(vi)
4 (vii)
Ph
Ph
O
O
O
O
OCH2Ph
HN
O
MeO
1
23
4
56
Ph
Ph
L1
5
O
PPh2
 
(vi) Dry DCM, Ph2CHCO2H, DCC, DMAP. (vii) Dry DCM, o-C6H4–PPh2–CO2H, DCC, DMAP; See 
experimental section for details. 
Scheme 2.5 
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The synthetic procedure for the ligand L2, starts from the amine 4‟ based 
on allose and proceeds with the same two condensation steps of standard 
nap-h. 
O
O
O
HO
OCH2Ph
NH2
MeO
1
23
4
56
O
O
O
HO
OCH2Ph
HN
O
MeO
1
23
4
56
(iv)
4' (v)
O
O
O
O
OCH2Ph
HN
O
MeO
1
23
4
56
L2
5'
O
Ph2P
Ph2P
Ph
Ph
 
Scheme 2.6 
 
The synthetic procedure for ligand L3 is different from the standard 
procedure of nap-h just in the first step where the glycosilation was 
perform in the presence of an acid resin in methanol (scheme 2.7).  
 
O
OH
NHAcHO
HO
HO
CH3OH, Amberlite, reflux, 24 h
(i)
O
OCH3
NHAcHO
HO
HO
1'' 2''
C6H4 CHO,
ZnCl2, 333 K , 2 h
Ph
HO
O
O
O OCH3
3''
EtOH, KOH, reflux 24 h
(ii)
(iii)
Ph
HO
O
O
O OCH3
4'' NHAc
NH2
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+
Ph
PhC
O
HO
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O
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L3
O
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O
Ph2P
O
O
Ph
Ph
O
Ph
 
 
               Scheme 2.7 
 
2.1.2  BISPYRIDYLAMIDES BASED LIGANDS
5 
 
Bispyridylamides, which still are the most efficient ligands for the Mo 
catalyzed process, are easily prepared from a picolinic acid derivative and 
a chiral enantioenriched 1,2-diamine.
[4]
 By comparing the results of 
reactions using ligands with substituted pyridine nuclei it was found that 
derivatives with π-donor substituents resulted in particularly high 
enantioselectivities and high branched to linear ratios.
[5]
 
                                                 
5
 Benessere, V.; Del Litto, R.; Ruffo, F.; Moberg, C. Eur. J. Org. Chem. 2009, 1352. 
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We report here the preparation of the new ligands and their use in Mo-
catalyzed allylic alkylations Ligands L4 was prepared from previously 
described diamino derivatives 4’’’[Errore. Il segnalibro non è definito.] and 
the picolinic acid  in the presence of carbonyl diimidazole (DCI) in 90% 
yield (scheme 2.8). 
 
                 scheme 2.8 
 
 
In order to verify the importance of the bispyridylamides backbone we 
also synthesized a bispyridylamides  ligand with an aminoalchol structure 
(L5),  starting from 4‟‟‟‟ with the same condensation procedure described 
above (scheme 2.9). 
 
 
O
O
O
HO
OCH2Ph
NH2
4''''
CDI, THF, 
50°C, Pic.Ac
O
O
O
O
OCH2Ph
HN
OO
N NL5
 
scheme 2.9 
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2.2 
1
H NMR CHARACTERIZATION OF THE LIGANDS 
 
All the ligands, naplephos(a–v) and L1-5, were characterised via NMR 
spectroscopy. The sugar protons were assigned according to both their 
expected chemical shifts and the consistence of the coupling constants 
within the glucose ring.  
The functionalization on C2 and C3 is easily recognized: the signal of the 
proton on the functionalized carbon is found at higher frequences (Δδ ≈ 2 
ppm) compared to the precursor. 
The 
1
H NMR spectra of OP and of all the ligands naplephos(a–v) and 
L1-5 are reported in succession. 
 
1
H NMR spectrum (300 MHz) of the OP intermediate 
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1
H NMR spectrum (300 MHz) of  naplephos-a 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
1
H NMR spectrum (300 MHz) of  naplephos-b 
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1
H NMR spectrum (300 MHz) of  naplephos-c 
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H NMR spectrum (300 MHz) of  naplephos-d 
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1
H NMR spectrum (300 MHz) of  naplephos-e 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
H NMR spectrum (300 MHz) of  naplephos-f 
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1
H NMR spectrum (300 MHz) of  naplephos-g 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
H NMR spectrum (300 MHz) of  naplephos-h 
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1
H NMR spectrum (300 MHz) of  naplephos-i 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
H NMR spectrum (300 MHz) of  naplephos-j 
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1
H NMR spectrum (300 MHz) of  naplephos-k 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
H NMR spectrum (300 MHz) of  naplephos-l 
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1
H NMR spectrum (300 MHz) of  naplephos-m 
 
 
 
 
1
H NMR spectrum (300 MHz) of  naplephos-n 
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1
H NMR spectrum (300 MHz) of the naplephos-o 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
H NMR spectrum (300 MHz) of the naplephos-o’ 
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1
H NMR spectrum (300 MHz) of the naplephos-p 
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1
H NMR spectrum (300 MHz) of the naplephos-p’ 
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Spettro 
1
H NMR (200 MHz) del legante naplephos-q 
 
 
 
Spettro 
1
H NMR (200 MHz) del legante naplephos-r 
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Spettro 
1
H NMR (200 MHz) del legante naplephos-v 
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1
H NMR spectrum (300 MHz) of the L1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
H NMR spectrum (300 MHz) of the L2 
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1
H NMR spectrum (300 MHz) of the L4 
 
 
 
1
H NMR spectrum (300 MHz) of the L5 
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2.3 THE HOMOGENEOUS PHASE  Pd-
CATALYSED ASYMMETRIC ALLYLIC 
ALKYLATION (AAA)  
 
2.3.1  GENERAL CONSIDERATION 
 
AAA (Scheme 2.10) has several applications in the field of target 
molecules synthesis of fine chemistry.
6
 As a matter of fact this reaction is 
involved in really versatile processes and are widely employed in the 
enantioselective formation of carbon-carbon or carbon-heteroatom bonds 
of optically active compounds,
7
 useful in biological, pharmaceutical or 
flavours field.  
 
X
Nu-
[Cat.]
13
Nu
3
Nu
13
1
 
Scheme 2.10 
 
AAA often  proceed under much milder conditions than ordinary SN2 or 
SN2‟ reactions, and with different chemo-, region- and stereoselectivies. 
Typical leaving groups are acetates and carbonates, rather then the more 
reactive halides or sulfonates, which may be a considerable advantage in 
the synthesis of complex multifunctional compounds.  
 
 
6
 (a)  Encyclopedia of Reagents for Organic Synthesis, L.A. Paquette, Ed.: J. Wiley and Sons: Sussex, 
England, 1996  (b) J.Tsuji, Tetrahedron Lett. 1965, 4387. (c) B.M.Trost, T.J.Fullerton, J.Am.Chem.Soc, 
1973, 95, 292. (e) Trost, B. M.; Tang, W.; Toste, J. Am. Chem. Soc. 2005, 127, 14785. 
7
 B. M. Trost Chem. Pharm. Bull. 2002 50(1) 1-14 and reference within. 
-X
- 
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By changing the metal or the ligand, it is often possible to tune the 
reactivity or selectivity of the catalyst, according to the specific 
requirement of a particular application. A variety of transition metal 
complexes derived from Pd, Ni, Ru, Rh, Ir, Mo, W, and other elements 
are known to catalyze AAA. The most widely used are Pd catalyzed 
reactions with “soft” nucleophiles, such as stabilized carbanions or 
amines.  
The variety of enantiodiscrimination mechanisms and bond types makes 
AAA promoted by Pd a good solution to simplify the synthetic strategy of 
elaborate intermediates and chemicals. 
 
 
2.3.2  REACTION MECHANISM 
 
The mechanism of Pd catalyzed AAA with soft nucleophiles has been 
firmly estabilished, and a detailed picture of the catalytic cycle can be 
drawn
8
 (Scheme 2.11).  
 
 
 
 
 
 
 
 
 
8
 (a) Tsuji, J.; Organic synthesis with Pd compounds. Sprinter, Berlin heidelberg New York, 1980 (b) 
Trost B.M.; Verhoeven T. R.; in : Wilkinson G.; Stone F.G.; Abel E.W.;(eds) Comprehensive 
organometallic chemistry. Pergamon, Oxford, chap 8 1982; (c) Godleski S.A. in: Trost B.M.; Fleming 
I.; Semmelhack M.F.; (eds) Comprehensive organic synthesis, Pergamon, Oxford, vol4, chap 3.3, 1991 
(d) Frost C.G.; Howart J., Williams J.M.J.; Tetrahedron asymmetry, 1992, 3, 1089 (e) Tsuji J.; 
Palladium reagnts and catalysts, innovation in organic synthesis, Wiley, Chinchester. 1995 (f) 
Heumann A., in: Beller M.; Bolm C. (eds) transition metals for organic synthesis, Wiley-VCH, 
Weinheim, vol1, chap 2.15; 1998 (g) Consiglio G.; Waymouth R.M.; Chem Rev 1989 89, 257 (h) 
Hayashi T. in: Ojima I. (ed) Catalytic assymmetric synthesis, VCH, New York, chap 7.1, 1993 (i) Trost 
B.M., Van Vranken D.L., Chem Rev 1996 96, 395 
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Scheme 2.11 
 
An allylic substrate I, tipically an acetate or a carbonate, react with the 
catalyst, which enters the catalytic cycle at  the Pd (0) oxidation level.  
Both Pd(0) and Pd (II) can be used as precatalysts, because Pd(II) is 
easily reduced in situ to activate Pd(0) form. The reaction is initiated by 
formation of a π-complex which eliminates X- to produce an (3-
allyl)Pd(II) complex. The product of this oxidative addition can be a 
cationic complex II, or a neutral complex if the resulting anion X
-
 
coordinates to the Pd. The equilibrium between cationic and neutral forms 
depends on the nature of the ligands as well as on other factors such as the 
solvent and the anion. Bidentate ligands usually favour the cationic form, 
which is more reactive towards nucleophiles, because of the strong 
preference of Pd(II) for a square-planar coordination geometry. Allyl 
complexes II can isomerize in various way (π-σ-π isomerization, apparent 
allyl rotation, Pd(0)-catalyzed allyl exchange), and this can have 
important consequences for the course of the reaction. If I has identical 
substituent at C1 and C3, starting from either enantiomer the same allyl-
palladium complex is formed. Therefore, the first part of the catalytic 
cycle leading to this intermediate usually is irrelevant for the 
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stereoselectivity of the overall reaction. The two termini of the free allyl 
are enantiotopic; if the catalyst is chiral, they become diastereotopic in the 
allyl-metal complex and, therefore, may hexibit different reactivities. 
The electrophilic Pd(II) center activates the allyl system for nucleophilic 
attack at the allyl termini. Addition of the nucleophile at C1 or C3 
generates an unstable Pd(0)-olefin complex III, which readly relases the 
final product IV and undergoes oxidative addition to another substrate 
molecule. 
 
 
 
2.3.3 CATALYTICAL TESTS ON rac-1,3-
DIPHENYL-2-PROPENYL ACETATE 
 
All the ligands synthesized were tested in the asymmetric allylic 
alkylation of rac-1,3-diphenyl-2-propenyl acetate with Sodium 
dimethylmalonate (Scheme 2.12) (see experimental section for detailes): 
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CH(CO2Me)2
 
Scheme 2.12 
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The results are reported in the following table (Table 2.1): 
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g, R= (S)-CHEt(Ph)
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k, R= Ph
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m, R= CH2Ph(2,5
-bis-Me)
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No. Ligand 
Cone 
angle
a
 (°) 
Charton 
parameter
a 
Conversion 
(%)
b
 
Time 
(h) 
ee (S)
c
 
(%) 
1 naplephos b 87 0.52 >99 8 39 
2 naplephos c 106 0.70 >99 5 85 
3 naplephos d 115  >99 2 87 
4 naplephos e 118 1.24 >99 2 89 
5 naplephos f 121 1.18 >99 2 91 
6 naplephos g 121 1.18 >99 2 86 
7 naplephos h 126 1.25 >99 2 91 
8 naplephos i 136  >99 18 80 
9 naplephos j 144  >99 18 80 
10 naplephos k   >99 18 45 
11 naplephos l   50 18 60 
12 naplephos m 160  >99 5 60 
13 naplephos n 160  70 24 63 
14 L1   >99 2 0 
15 naplephos a   >99 2 -33 (R) 
16 OP   80 18 50 
17 naplephos o    >99 18 70 
18 naplephos o’   >99 18 -50 (R) 
19 naplephos p   >99 18 70 
20 naplephos p’   60 18 -20 (R) 
21 naplephos q    >99 18  70 
22 naplephos r   >99 18  73 
23 naplephos s 87  >99 12 30 
24 naplephos t 106  >99 18 61 
25 naplephos u 118  >99 18 90 
26 naplephos v   >99 18 52 
 
Reaction conditions: rt, 0.25 mmol of substrate, 0.75 mmol of dimethylmalonate, 0.75 mmol of NaH, 
0.0050 mmol of [Pd(μ-Cl)(3-C3H5)]2, 0.022 mmol of ligand.
 
a Relative to the R substituent at the carbonyl α-position. Taken, respectively, from Refs. 8 and 9(a),(b). 
b Evaluated by NMR spectroscopy of the crude reaction mixture. 
c
 Determined by HPLC on Chiracel OD-H, using 2-propanol/hexane 2:98, 1.0 mL/min, UV, 254 nm. (R) 
9.6min., (S) 10.3 min. 
Table 2.1 
 
 50 
After some preliminary runs, the ligand/Pd ratio was conveniently set to 
2:1 in most of the experiments (see below). All the reactions were 
complete within a few hours, affording the expected product as the only 
one. A neat trend was observed, in that both the conversion and the 
enantioselectivity showed a clear dependence upon the steric hindrance of 
the ester substituent in 3 (Table 2.1 also reports both the cone angles
9
 and 
the Charton parameters
10
 of some R group). The gradual increase in the 
dimension of the R group along the series naplephos-b through 
naplephos-h (entries 1–9) enhances the performance of the catalyst, 
reaching a maximum which corresponds to a cone angle within 120–126° 
(entries 5–7). Further enlargement decreases both the activity and the 
selectivity (entries 8–9). The presence of an additional stereocenter in the 
ester group R has little effect on the catalyst performance. In fact, similar 
enantioselectivity and conversion rate were observed when using 
naplephos- f and naplephos-g (entry 5 vs entry 6), which only differ in 
the configuration of this substituent [R = (R)-CH(Et)Ph and (S)- 
CH(Et)Ph, respectively]. In other words, the significant steric role of the 
substituent is independent of its configuration. Naplephos-k and 
naplephos-o have similar hindrance, but differ for the coordinating 
ability of Py versus Ph. The similarity of the performance of this two 
ligands (same activities, mediocre enantioselectivity) confirm what was 
demonstrated by study on naplephos o-v ligands (entry 17-26), i.e. tuning 
of the steric hindrance on the C3 is more important than tuning the 
electronic proprieties on the same group for this ligands, in this case N sp
2
 
or sp
3
. According to this behaviour when we use different steric hindrance 
also on a sp
3  
N atom we just have significant enhancement in ee with 
more bulky group (entry 23-26).  
 
9
 Taken from: http://www.bu.edu/qale/. 
10 (a) Charton, M. J. Am. Chem. Soc. 1969, 91, 615; (b) Charton, M. J. Am. Chem. Soc. 1975, 97, 3691. 
(c) Sigman, M. S.; Miller, J. J. J. Org. Chem. 2009, 74, 7663. 
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A particular, but not efficient, chiral pocket is active when ligand 
naplephos o’-p’ are used: in this case we have a different enantiomer 
(+R), probably because the steric hindrance on C2 change the isomer of 
the phosphinoamide. Ligand L1 gave no enantioselection, probably 
because  different active species are involved.  
Thus, best results were obtained with naplephos-h [R=CHPh2], which has 
afforded the product in 91% ee under the given experimental conditions. 
Naplephos-h was therefore selected for further refinement of the results, 
as reported in Table 2.2. 
 
No. Nucleophile L/Pd Additive 
Conversion
b
 
(%) 
Time 
(h) 
ee
c
 (S) 
(%) 
1
a 
NaCH(CO2Me)2 1.1/1 - >99 18 80 
2
a 
NaCH(CO2Me)2 2/1 - >99 2 91 
3
a 
NaCH(CO2Me)2 4/1 - >99 0.2 96 
4
d,a 
NaCH(CO2Me)2 2/1 - >99 2 90 
5
e 
NaCH(CO2Me)2 2/1 - >99 2 93 
6
a 
NaCH(CO2Me)2 2/1 Bu4NBF4
f 
70 4 95 
7
a 
BSA/CH2(CO2Me)2 2/1 KOAc
g 
>99 5 70 
8
a 
BSA/CH2(CO2Me)2 2/1 LiOAc
g 
>99 5 86 
a
 Reaction conditions: rt, 0.25 mmol of substrate, 0.75 mmol of nucleophile, 0.0050 mmol of [Pd(-
Cl)(3-C3H5)]2. 
b
 Evaluated by NMR spectroscopy of the crude reaction mixture. 
c
 Determined by HPLC on Chiracel OD-H, using 2-propanol/hexane 2:98, 1.0 mL/min, UV, 254 nm. 
(R) 9.6min., (S) 10.3 min. 
d
 The catalyst was treated with a stoichiometric amount of AgBF4 prior the addition of the reagents. 
e
 Reaction conditions: rt, 0.10 mmol of substrate, 0.30 mmol of nucleophile, 0.0050 mmol of of [Pd(-
Cl)(3-C3H5)]2. 
f
 0.75 mmol. 
g 0.010 mmol. 
Table 2.2 
 
 
The performance of the catalyst could be greatly improved upon by 
increasing the ligand/Pd ratio (entries 1–3), and the conversion was 
complete in only 10 min with an ee of 96% when 4 equiv of ligand was 
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added (entry 3). The addition of a tetrabutylammonium salt (entry 6) 
increased the enantioselectivity although the reaction rate did decrease. 
The performance of the catalyst was nearly identical when the chloride 
ion was preliminarily precipitated as a silver salt (entry 4), while the 
generation of the nucleophile by using BSA  resulted in lower reaction 
rates and ee‟s (entries 7 and 8).  
 
2.3.4 INTERPRETATION OF THE RESULTS AND 
STUDY OF THE COMPLEX  
 
A key argument for the interpretation of the results collected in Tables 
2.1 and 2.2 is the strong dependence of the catalyst‟s performance on (i) 
the ligand/palladium ratio (entries 1–3 of Table 2.2) and (ii) the steric 
hindrance of the R group at the 3-position. Therefore, some experiments 
were addressed to study the coordination modes of naplephos-h as a 
function of the ligand/Pd ratio. In the first test, 1 equiv of naplephos-h 
was added to a THF-d8 solution of the cationic precursor [Pd(THF-
d8)n(
3
-C3H5)]
+
(TfO
-
).
11,12 The following pieces of diagnostic evidence 
were observed in the NMR spectra of the resulting complex: 
 
– A shift at high frequency ( 8.82) of the NH signal in the proton 
spectrum with respect to the free ligand ( 7.70).  
 
11
 Prepared by mixing [Pd(-Cl)(3-C3H5)]2 with a stoichiometric amount of AgOTf in 0.6 mL of THF-
d8. After filtering AgCl, naplephos-h was added to the solution affording the complex. The decision to 
generate a cationic species by removing the chloride ion from the solution aimed at simulating the 
catalytic conditions. In fact, it is likely that in the presence of a large excess of sodium ions coming 
from the malonate salt, precipitation of NaCl occurs, affording cationic Pd compounds, as also 
proposed by other authors (see reference 11) 
12
 (a) Tollabi, M.; Framery, E.; Goux-Henry, C.; Sinou, D. Tetrahedron: Asymmetry 2003, 14, 3329; 
(b) Konovets, A.; Głegola, K.; Penciu, A.; Framery, E.; Jubault, P.; Goux-Henry, C.; Pietrusiewicz, K. 
M.; Quirion, J. C.; Sinou, D. Tetrahedron: Asymmetry 2005, 16, 3183; (c) Amatore, C.; Jutand, A.; 
Mensah, L.; Ricard, L. J. Organomet. Chem. 2007, 692, 1457; (d) Marinho, V. R.; Rodriguez, A. I.; 
Burke, A. J. Tetrahedron: Asymmetry 2008, 19, 454. 
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– The presence of a single resonance at  23.3 in the P spectrum.  
– A shift at high frequency from  169.4 to  173.2 of the amido 
carbonyl group in the carbon spectrum. 
 
According to previous literature,13 all these features do clearly indicate 
P,O-chelation through the amide carbonyl function at the 2-position (see 
Figure 9 for the [Pd(3-allyl)(P,O-naplephos-h)]+ complex), and, hence, 
in the presence of only 1 equiv of ligand, the active species are plausibly 
cationic chelated complexes [Pd(3-allyl)(P,O-naplephos )]+. 
 
Figure 9 
 
More interesting within this context is what happened upon the addition 
of the second equivalent of ligand to [Pd(3- C3H5)(P,Onaplephos-h)]
+
, 
because these are the conditions which largely favour both conversion 
and ee (e.g., entry 1 vs entry 2 of Table 2.2). The immediate 
phosphorous spectrum displayed the signal of the free ligand at  -9.5, 
along with the aforementioned signal at  23.3. On standing, the former 
signal gradually decreased, while a new singlet at  28.5 grew. After a 
few hours this was by far the prevailing species.  
 
13
 (a)Głegola, K.; Framery, E.; Goux-Henry, C.; Pietrusiewicz, K. M.; Sinou, D. Tetrahedron 2007, 63, 
7133 (b) Tollabi, M.; Framery, E.; Goux-Henry, C.; Sinou, D. Tetrahedron: Asymmetry 2003, 14, 3329 
(c) Butts, C. P.; Crosby, J.; Lloyd-Jones, G. C.; Stephen, S. C. Chem. Commun. 1999, 1707 (d) 
Mahadik, G. S.; Knott, S. A.; Sezezepura, L. F.; Peters, S. J.; Standard, J. M.; Hitchcock, S. R. J. Org. 
Chem. 2009, 74, 8164. 
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The contemporaneous shift of the NH signal from  8.82 to the original 
region at around  7.7 was also observed. This finding strongly indicates 
competitive coordination of two phosphines in a C2-symmetrical fashion 
affording a more active catalytic species when the   ligand/Pd ratio is 
equal to two or higher. By combining these pieces of evidence with the 
aforementioned dependence of the enantioselectivity on the hindrance of 
R, the results can be interpreted by assuming that two phosphines 
coordinate as illustrated in Figure 10  which represents the most active 
-allyl intermediate of the catalytic cycle.14 According to the mechanism 
proposed by Pfaltz for C2-symmetrical ligands,
15
 the enantioselectivity 
originates from the different rates of nucleophilic attacks (i and ii) at the 
allyl carbon termini. These are governed by the rotation
16
 of the allyl 
fragment to give (S)-product and (R)-product, respectively, coordinated 
in an 2-fashion in P1 and P2. In this case, it is clear how the attainment 
of P2 is hampered by steric repulsion between the substituents on the (R)-
product and R, and, as a consequence, a gradual increase of the cone 
angle of R regularly favours the formation of (S)-product.  
 
 
 
 
 
 
 
 
 
 
14 Tsuji, J. Palladium Reagents in Catalysis. In Innovation in Organic Synthesis; Wiley: New York, 
1995 
15
 Pfaltz, A.; Lautens, M.. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., 
Yamamoto, H., Eds.; Springer: Berlin, 1999; Vol. 2, Chapter 24; 
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Figure 10 
 
Furthermore, in the P,P-coordination mode, the N–H units are available 
for hydrogen-bond interactions with the carbonyl nucleophile, an 
additional feature which can be beneficial for both rate and selectivity.
16
 
This is also in agreement with the fact that the R group is sterically 
effective, but stereochemically inactive (see above, entry 5 vs entry 6), 
and with the observation that the enantioselectivity of the reaction is 
mainly governed by the pocket created by the chiral ligands. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
Butts, C. P.; Filali, E.; Lloyd-Jones, G. C.; Norrby, P.-O.; Sale, D. A.; Schramm, Y. J. Am. Chem. 
Soc. 2009, 131, 9945. 
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2.3.5 FURTHER REFINEMENT IN USE OF 
NAPLEPHOS LIGANDS
17 
 
As mentioned in the Introduction, naplephos ligands have already been 
investigated in the asymmetric allylic alkylation of 1,3-
diphenylpropenylacetate with dimethylmalonate. In a recent paper, we 
described how both the steric hindrance in 3 and the ligand:Pd ratio are 
decisive for the enantioselectivity of the reaction. In fact, naplephos-h 
produces the (S)-product in ee‟s up to 96% by increasing the ligand:Pd 
ratio up to 4:1, with dry THF as solvent, and Na(CHCO2Me)2 as the 
nucleophile (Table 1).  
Although in these conditions the reaction is fast and selective, we were 
strongly motivated to assess the performance of the ligands in other 
conditions, aiming to (i) use lower and more convenient ligand:Pd ratios, 
(ii) reduce the impact of the process, (iii) save precious chemicals, (iv) 
confirm the versatility of the ligands, (v) re-cycle the metal catalyst. The 
first conditions can be in principle satisfied by using dichloromethane as 
solvent, since the reactions can be performed in milder conditions by 
generating the nucleophile with BSA. 
As for the catalyst recycle, a proven alternative is the use of an 
unconventional solvent, such as an inexpensive ionic liquid, capable of 
selectively dissolving the metal catalyst. 
On these basis, the allylic alkylation of 1,3-diphenylpropenylacetate with 
dimethylmalonate was first performed in dry dichloromethane by setting 
the naplephos:Pd ratio to 1:1, and by generating the nucleophile in the 
presence of BSA and a pinch of lithium acetate.  
 
 
17
 Benessere, V., Lega, M., Ruffo, F., in press   
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no. ligand cone angle
a 
(°) 
(Charton parameter)
a
  
conditions conversion
c
 
(%) 
time 
(h) 
ee(S)
b
 
% 
1 naplephos-c 106 (0.70) c 99 5 85 
2 naplephos-c 106 (0.70) d 99 18 88 
3 naplephos-f 121 (1.18) c 99 2 91 
4 naplephos-f 121 (1.18) d    
5 naplephos-g 121 (1.18) c 99 2 86 
6 naplephos-g 121 (1.18) d    
7 naplephos-h
a
 126 (1.25) c 99 2 91 
8 naplephos-h 126 (1.25) d 99 18 96 
8 naplephos-i
a
 136 c 99 18 80 
8 naplephos-i 136 d 99 18 96 
9 naplephos-j
a
 144 c 50 18 80 
10 naplephos-j 144 d 99 18 76 
a
Relative to the R substituent in the carbonyl  position. Respectively taken from references 8 and 9.  
b
Evaluated by NMR spectroscopy of the crude reaction mixture.  
c
Reaction conditions: RT, THF, 0.25 mmol of substrate, 0.75 mmol of dimethylmalonate, 0.75 mmol 
of NaH, 0.0050 mmol of [Pd(-Cl)(3-C3H5)]2, 0.022 mmol of naplephos.  
d
Reaction conditions: RT, dichloromethane, 0.25 mmol of substrate, 0.75 mmol of dimethylmalonate, 
0.75 mmol of BSA, 0.0050 mmol of [Pd(-Cl)(3-C3H5)]2, 0.010 mmol of naplephos, pinch of 
LiOAc.  
Table 2.3 
 
A comparison of the results (Table 2.3) with those obtained in THF 
(Table 2.1-2.2) discloses two important trends. First, analogous steric 
effects hold true in the two solvents, in that the higher ee is achieved with 
naplephos-h (ee 96%), while more or less crowded ligands produce a less 
enantiorich product. 
Furthermore, the effect of the ligand concentration is reversed. When 
ligand:Pd ratios higher than 1:1 were used in dichloromethane, both 
conversion and enantioselectively were depressed. This effect is 
reproducible, although its origin is not yet clearly explained (nota).   
The steric effect can be reasonably elucidated on the grounds of both 
literature results and molecular models. It is likely (stessa nota) that the 
ligands coordinate Pd through the phosphorous atom and the amido 
carbonyl oxygen in position 2, and, hence, oxidative addition of the 
acetate affords the two diastereomeric π-allyl intermediates P1 and P2 
(Scheme 2.13).  
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On the grounds of the acknowledged mechanism, nucleophilic attack of 
malonate takes place preferentially at the allyl carbon atom trans to P, 
with formation of the corresponding alkene products Ak1 and Ak2. 
Enantioselectivity ensues from the diverse rates of nucleophilic attack. By 
assuming that the geometry of the transition state of the attack is close to 
that of Ak1 and Ak2, it is reasonable that K1>K2, because Ak2 is 
selectively hindered by the ester substituent in 3. Thus, a bulky R group 
(i.e., R= CHPh2) helps the enantioselectivity, although  undue hindrance 
(e.g., R= CHCy2) reduces the catalyst‟s performance, plausibly because it 
hampers the carbonyl coordination, and the steric control moves away 
from the catalytic centre. 
Addition of one equivalent of naplephos-h to a CD2Cl2 solution of π-
[PdCl(π3-allyl)]2 results in immediate formation of the expected 
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diastereomeric couple of π-allyl species [Pd(P,O-naplephos-h)(π3-
allyl)]Cl. Further addition of ligand simply results in the growth of the 
signal pertaining to the free ligand.  
We also investigated other different modifications on the structure of 
naplephos ligands and in particular we changed the relative absolute 
configuration of the C3 using a ligand based on allose (L2), and the bulky 
group in position 1 (L3) substituting the benzyl group with a methyl 
group in order to define some secondary steric effect on the catalysis that 
can influence the performance not just near the catalytic centre but from 
the backbone. Results are reported in the table below. 
 
O
O
O
O
OCH2Ph
HN
O
MeO
1
23
4
56
L2
O
Ph2P
Ph
Ph
                                 L3
O
OCH3
HNO
O
Ph2P
O
O
Ph
Ph
O
Ph
 
no. ligand cone angle
a 
(°) 
(Charton parameter)
a
  
conditions conversion
c
 
(%) 
time 
(h) 
ee(S)
b
 
% 
1 naplephos-h 126 (1.25) d 99 18 96 
2 L2 126 (1.25) d 20 18 0 
3 L3  d 99 18 83 
 
Table 2.4 
 
As it‟s clear from the analysis of the Table 2.4 when we use ligand L2 
with the same steric parameters but a different absolute configuration 
only at C3 we can observe a dramatic change of catalytic activity due to 
the different orientation of the bulky group that doesn‟t have the effect to 
produce the other enantiomer gives rise to a complete different active 
specie. 
No important effects, but there is an effect, are observed when we change 
the group in position 1 (L3). 
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2.4 NAPLEPHOS IN MULTIPHASE CATALYSIS: 
PRELIMINARY WORK
17 
 
Ionic liquids are among the most promising green solvents.
18
 Though 
their use does not require specific tagging of the catalysts, in several 
occasions their affinity for the ionic liquid demonstrated to improve 
fruitfully with the polarity of the ligands. This also inhibits leaching of the 
catalyst in the organic product phase, and increases the possibility of 
further catalyst re-cycles.  
This approach has been pursued during this thesis, by providing selected 
naplephos ligands of appropriate tags (Figure 3), whose choice has been 
dictated by at least three important considerations. First, the tag must be 
polar or ionic, for securing solubility in the ionic solvent. Then, its 
structure must preserve the conformational rigidity of the glucose chair, 
as the benzylidene ring is able to do. Furthermore, the synthesis must be 
straightforward and easy to carry out.  
We devised an approach which combines these benefits by introducing a 
4,6-phosphate moiety within the sugar ring, as depicted in Scheme 2.14  
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 61 
By reacting the 4,6-deprotected precursors 6 and 7 with POCl3 in dry 
dichloromethane, the corresponding 4,6-oxychlorophosphate compounds 
naplephos-a’ and naplephos-h’ were isolated in high yield. Subsequent 
controlled hydrolysis of the P-Cl bond in a water/dioxane mixture 
afforded the ionic products naplephos-a” and naplephos-h” as their tetra-
n-butylammonium salts.    
The ligands were characterised through NMR spectroscopy. As 
anticipated, the 4,6-phosphate ring assumes a chair conformation, which 
is clearly revealed by the coupling constants within the sugar protons. In 
naplephos-a’ and naplephos-h’ the phosphorous atom in the phosphate 
ring is stereogenic, and two diastereomers can be observed in solution. 
However, given the significant distance of this stereochemical motif from 
the active catalytic centre, its presence is not expected to have any control 
in the enantioselectivity of the process to be catalysed.  
Most important, both neutral and cationic phosphate ligands display high 
solubility in the ionic liquid used for most of the experiments, 
BMIM[BF4], as well as in common organic solvents (THF, 
dichloromethane, chloroform or toluene).  It is interesting to note that, 
from preliminary catalytic results, the 4,6-phosphate species naplephos-h’ 
and naplephos-h” induce very similar enantioselectivities, thus 
demonstrating that the presence of the phase-tag has no effect on the 
stereochemistry of the reaction, but a great effect on the physical-
chemical properties of the catalyst. 
 
 
 
 
 
 
 
 
 
18
Ionic Liquids in Synthesis; Eds: P. Wasserscheid, T. Welton, Wiley-VCH: Weinheim, Germany, 
2003. 
19
 Multiphase Homogeneous Catalysis, 1st ed.; Eds: B. Cornils, W.A. Herrmann, I.T. Horvarth, W. 
Leitner, S. Mecking, H. Olivier-Borbigou, D. Vogt, Wiley-VCH: Weinheim, Germany, 2005. 
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2.5 Mo-CATALYSED AAA PROMOTED BY µW 
 
Catalysts containing palladium have been most extensively employed in 
synthetic applications,
22
 but may lead to undesired products when 
unsymmetrically substituted allyl derivatives are used.
23
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                          Moberg’s ligand                                                                     L4 
Figure 11 
 
Thus, whereas palladium complexes as a rule afford the achiral linear 
products from monosubstituted allylic substrates,
24
 complexes based on Ir 
and Mo have a preference for formation of the branched chiral products. 
With the introduction of (R*,R*)-1,2-diaminocyclohexane (Figure 11)
25 
as ligand by Trost,
26
 highly enantioselctive Mo-catalyzed allylations 
became possible. Although Ir catalysts have a wider scope,
27
 catalysts 
containing Mo have become attractive due to the lower cost of 
molybdenum as compared to iridium and the robustness of the in situ 
formed catalytic system.
28
 These factors together with our simple 
experimental protocol using microwave irradiation, allowing the catalytic 
reactions to be run within less than 10 minutes in air using stable, 
crystalline, commercially available Mo(CO)6 as catalyst precursor,
29
 have 
made Mo catalysts viable alternatives to those based on Pd and Ir for a 
variety of applications. 
Bispyridylamides, which still are the most efficient ligands for the Mo 
catalyzed process, are easily prepared from a picolinic acid derivative and 
a chiral enantioenriched 1,2-diamine.
30
 By comparing the results of 
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reactions using ligands with substituted pyridine nuclei it was found that 
derivatives with -donor substituents resulted in particularly high 
enantioselectivities and high branched to linear ratios.
31
 C2-Symmetric 
1,2-diaminocyclohexanes have commonly been used as ligand precursors 
together with picolinic acid derivatives. In the search for more easily 
available diamines, Lloyd Jones, Kocovsky and co-workers used 
asymmetric diamines derived from naturally occurring amino acids.
32
 The 
ligands obtained provided catalysts, some of which exhibited high 
enantio- and regioselectivity and high reactivity. 
Carbohydrates are other examples of useful naturally occurring starting 
materials for ligand synthesis, and they are particularly attractive as they 
are available in several stereoisomeric forms.
33
 -D-Glucose34 and -D-
mannose
35
derivatives with amino substituents in the 2- and 3-positions of 
the carbohydrate have been described and have successfully been used for 
the preparation of ligands which have been applied in metal-catalyzed 
enantioselective processes. Inspired by the structural analogy between 
trans-cyclohexanediamine and the glucose derivative and by the 
possibility to obtain a chiral cis-substituted ligand from mannose, we 
decided use the two 1,2-diamines for the preparation of bispyridylamides. 
The catalytic reactions were performed using our previously developed 
experimental conditions. Thus, Mo(CO)6, ligand, allylic carbonate 8, 
dimethyl malonate, and N,O-bis(trimethylsilyl)acetamide were mixed in 
THF and heated at 160 °C in the microwave cavity under air. After 
completed reaction, conversions and branched to linear ratios were 
determined by 
1
H NMR spectroscopy and gas chromatography, 
respectively, and enantioselectivities by chiral HPLC. First the three types 
of ligands were assessed using 4 and/or 10 mol % Mo, a nucleophile to 
substrate ratio of 1.1:1, and a ligand to metal ratio of 1.3:1. The results of 
these initially performed reactions are shown in Table 2.5. In reactions 
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using L4 and L4’, (R)-(+)-dimethyl 3-phenyl-1-butene-4,4-dicarboxylate 
was formed as the major product, whereas the opposite enantiomer was 
obtained in reactions with L4’’. Higher catalyst loadings resulted not only 
in higher reactivity but also in higher regioselectivity (entries 1 and 4 vs 2 
and 5, respectively). In contrast to results obtained with ligands derived 
from 1,2-diaminocyclohexane, the p-chloro-substituted derivative (entry 
3) gave the product with lower enantioselectivity than L4. The 
enantioselection of ligands prepared from the pseudo-C2-symmetric 2,3-
gluco derivatives L4 and L4’ turned out to be far superior to that of 
pseudo-Cs-symmetric 2,3-manno diamide L4’’(38-40% ee, entries 3 and 
4). L4 was thus the ligand of choice, exhibiting higher reactivity and 
providing higher enantioselectivity (99% ee) and higher branched to 
linear ratio (49/1 using 10 mol % catalyst) than L4’ and L4’’. Reactions 
using this ligand were therefore studied in more detail.  
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Table 2.5. Molybdenum-catalyzed asymmetric substitutions of 4 using 
ligands L4-4’-4’’.[a] 
Entry Ligand 
Ligand 
Cat.(%) Conversion
a
 (%) Regiosel.
[b] 
(10/11)
 
 
Regiosel.
a
 
Ee
[c]
 (%)
 
1 4 10 96 49/1 99 (R) 
2 L4 4 50 8/1 99 (R) 
3 L4’ 4 42 12/1 87 (R) 
4 L4’’ 10 76 14/1 38 (S) 
5 L4’’ 4 41 5/1 40 (S) 
[a] Reactions were run at 160 °C for 6 min. with ligand:metal = 1.3:1 and Nu:4 = 1.1:1.[b]Determined 
by GC-MS. [c] Determined by HPLC using a Daicel OD-H (0.46 cm Ø x 25 cm) column. 
 
The following catalytic reactions using L4 were performed employing the 
same procedure as that used in the initial reactions, but equimolar 
amounts of nucleophile and substrate, and lower ligand to metal ratios 
(1.1:1) were used. These conditions allowed isolation of pure products by 
bulb-to-bulb distillation; in some reactions the product was isolated by 
chromatography, which resulted in lower yields. Again, lower amounts of 
catalyst resulted in lower conversion and lower regioselectivity (Table 
2.6, entries 1-3), although the enantioselectivity remained high (99% ee). 
With 4 mol % catalyst, the conversion was merely 50% after 6 minutes 
(entry 3). Prolonged reaction times resulted in further product formation, 
which however ceased after 15 minutes (entries 4 and 5), probably due to 
decomposition of the catalyst; this decomposition could not be prevented 
by higher ligand loading (entry 6). With 1 mol % catalyst somewhat 
lower enantioselectivity (94% ee) and very low regioselectivity were 
observed (entry 7). The best result, obtained with 10% catalyst loading, 
(entry 1) allowed the product with a branched to linear ratio of 49/1 to be 
isolated in 90% yield (99% conversion).  
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Table 2.6 Molybdenum-catalyzed asymmetric substitutions of 8 using 
ligand L4.
[a]
 
Entr
y 
Cat.(%) Mo/Lig
. 
Time 
(min) 
Conversion
[b]
 
(%) 
Yield (%) Regiosel.
[c]
(10/11)
 
 
Regiosel.
a
 
Ee
[d]
 
(%)
 1 10 1/1.1 6 99 90
[e] 
49/1 99 
2 5 1/1.1 15 78 38
[f]
 9/1 99 
3 4 1/1.1 6 50 35
[f]
 8/1 99 
4 4 1/1.1 15 65 33
[f]
 8/1 99 
5 4 1/1.1 30 65 35
[f]
 8/1 99 
6 4 1/1.5 15 50 35
[f]
 8/1 99 
7 1 1/1.1 30 10 7
[f]
 1.5/1 94 
8 10 No Lig 6 25 n. d.
[g]
 4/1 - 
[a] Reactions were run at 160 °C with ligand:metal = 1.1:1 and Nu:4 = 1:1. [b] Determined by 
1
H 
NMR. [c] Determined by GC-MS. [d] Determined by HPLC using a Daicel OD-H (0.46 cm Ø x 25 cm) 
column. [e] Isolated by bulb-to-bulb distillation. [f] Isolated by chromatography on silica gel (eluent 1/1 
Peth.ether/DCM). [g] not determined. 
 
Mo-catalyzed allylic alkylations are known to proceed via π3-allyl 
molybdenum complexes, which are formed by oxidative addition of the 
allylic carbonate to ligated Mo(0).
37
 The reactions proceed 
stereospecifically by syn displacement of the carbonate.
38
 For this reason 
diastereomeric allyl complexes are formed from the two enantiomers of 
branched carbonates such as 9. In order to achieve high enantioselectivity 
in reactions with branched racemic substrates, equilibration of the 
diastereomeric allyl complexes via π3  π 1  π 3 isomerization therefore 
needs to be rapid in relation to nucleophilic attack, which also occurs by a 
syn mechanism. Under certain conditions equilibration is incomplete, 
resulting in modest memory effects and, as a consequence, in lower 
enantioselectivities than in reactions with linear substrates.
39
  
The results from reactions with rac-9 using the present catalytic system 
are shown in Table 2.7. The branched substrate 9 gave the product with 
lower enantio- and regioselectivity than the linear substrate, but the 
conversion remained high when the catalyst loading was decreased from 
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10 (entry 1) to 5 mol % (entry 2). With a further decrease of the amount 
of catalyst, the conversion decreased and with 1% catalyst merely 15% 
conversion was observed after 30 minutes (entry 4). No major difference 
was observed between reactions run in THF and in toluene (entries 2 and 
3).  
Table 2.7. Molybdenum-catalyzed asymmetric substitutions of rac-9 
using ligand L4.
[a]
 
Entr
y 
Cat.(%) Mo/Lig. Time 
(min) 
Conversion
[b]
 
(%) 
Yield 
(%) 
Regiosel.
[c]
(6/7)
 
 
Regiosel.
a
 
Ee
[d]
 
(%)
 
1 10 1/1.1 6 99 82
[f] 
8/1 96 
2 5 1/1.1 15 99 90
[f]
 8/1 95 
3 5 1/1.1 15
[e]
 99 85
[f]
 8/1 96 
4 1 1/1.1 30 15 12
[g]
 8/1 80 
5 10 No Lig 6 50 n. d.
[h]
 5/1 - 
[a] Reactions were run at 160 °C with ligand:metal = 1.1:1 and Nu:5 = 1:1. [b] Determined by 
1
H 
NMR. [c] Determined by GC-MS. [d] Determined by HPLC using a Daicel OD-H (0.46 cm Ø x 25 cm) 
column. [e] Reaction run in toluene. [f] Isolated by bulb-to-bulb distillation. [g] Isolated by 
chromatography on silica gel (eluent 1/1 Peth.ether/DCM). [h] not determined. 
 
In the π3-allyl complex obtained after oxidative addition of the allylic 
carbonate, the ligand has been shown to coordinate to Mo in a tridentate 
manner via one pyridine nitrogen, one deprotonated amide nitrogen, and 
one carbonyl oxygen atom.
40
 Assuming the same configuration at the 
metal center as that found for the complex containing ligand in Figure 11, 
two modes of coordination (A and B, Figure 12) are possible for 
asymmetric ligand L4, and thus two complexes leading to the observed 
product, due to the lack of twofold rotational axis.  
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Figure 12 
 
A catalytic run failed when the pyridylamide derived from a 4,6-O-
benzylidene-2-amino-2-deoxyglucoside scaffold was used (Figure 13). 
This suggests that the NH function in position 3 is essential for the 
reaction, and, hence, diasereomer A should be the actual allyl 
intermediate. Although a catalyst containing (R)-1-(2-
pyridinecarboxamido)-2-(2-pyridinecarboxy)-1-phenylethane (L5’), an 
ester–amide, has been shown to exhibit some activity in Mo-catalyzed 
allylic substitutions, no product formation was observed when 
monoamide L5, derived from a 2-amino-4,6-O-benzylidene-2-
deoxyglucoside scaffold, was used as ligand.  
                    L5’                                                                       L5 
Figure 13 
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CHAPTER 3 
CONCLUSIONS 
 
 
 
The simple functionalisation of commercially available N-
acetylglucosamine provides the efficient library of chiral ligands 
naplephos (Figure 3.1).  
 
O
O
O OR'
HN
O
P
PhPh
O
O
R
phase tag
coordinating function
hemilabile coordination sites
steric control
1
23
4
5
6
naplephos  
Figure 3.1 
 
Along with an anomeric -benzyl group and the rigid benzylidene ring in 
C4 and C6, the distinctive feature of the ligands is a coordinating 
diphenylphoshino arm in the equatorial 2-position. Esterification at the 3-
position with readily accessible carboxylic acid RCO2H allows to 
functionalise the ligands with fine control of the steric hindrance. The 
experimental work carried out during this thesis project demonstrated that 
the basic structure naplephos, alredy successfully employed in the 
copper-catalyzed 1,4 addition of dialkyl zinc on conjugated enones and in 
the Pd-catalysed asymmetric desymmetrization of meso-2-cyclopenten-
1,4-diol biscarbamate, may be effectively adapted to the Pd-allylic 
alkylation of the rac-1,3-diphenyl-2-propenyl acetate, leading up to 96% 
ee% (Scheme 3.1).  
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Scheme 3.1 
 
An NMR study of the foundamental intermediate involved in this reaction 
was carried out, providing useful information on the reaction mechanism 
and its stereochemical control. 
Further investigation proved the versatility of these structure that can 
display both PP and PO coordination motifs to be active in THF and 
DCM respectively.  
We also demonstrated the possibility to perform multiphase catalysis in 
ionic liquids through simple modification of this class of ligand and to 
pave the way for further study that can confirm the catalyst re-cycle 
(Figure 3.2). 
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Bis(pyridine-2-carboxamides) were conveniently prepared from 1,2-
diamines obtained from á-D-glucose according to known procedures and 
shown to serve as efficient ligands in Mo-catalyzed microwave-mediated 
asymmetric allylic alkylations. The two types of structures allowed the 
comparison of ligands having the amide arms in trans and cis positions in 
the six-membered ring. The former type of ligands proved to be more 
successful, providing the product, (+)-(R)-dimethyl 3-phenyl-1-butene-
4,4-dicarboxylate, with 99% enantiomeric excess and with a 
branched/linear ratio of 49:1 in 90% isolated yield under optimized 
conditions. 
O
O
O
NH HN
O
NN
O
OCH2Ph
 
    L4 
                                                           Scheme 3.2
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CHAPTER 4 
EXPERIMENTAL SECTION 
 
 
4.1 GENERAL CONSIDERATIONS 
 
NMR spectra were recorded in CDCl3 (CHCl3,  7.26, and 
13
CDCl3  77, 
as internal standards) with a 200 and 300 MHz spectrometers (Varian 
Model Gemini, at the CIMCF of the “Università degli studi di Napoli 
Federico II”), or with a 270 MHz spectrometer (JOEL EX270, at the 
“University of Nottingham”). The following abbreviations were used for 
describing NMR multiplicities: s, singlet; d, doublet; dd, double doublet; 
t, triplet; dt, double triplet; m, multiplet; app, apparent. Specific optical 
rotatory powers [] were measured with a Perkin– Elmer Polarimeter 
(model 141) at 298 K and 589 nm in chloroform (c 1.0 g/100 mL) (at the 
“Università degli studi di Napoli Federico II”). Microwave heating was 
performed by using a Smith Creator single-mode cavity from Biotage 
(KTH Sweden, Prof. Moberg‟s Lab). Benzyl-4,6-O-[(4-MeO)-
benzylidene]-2- deoxy-2-amino-a-D-glucoside (intermediate 4 of Scheme 
2.1), and the naplephos-a were prepared according to literature methods
1
. 
THF and MTHF were distilled from LiAlH4, dichloromethane from CaH2, 
toluene and Et2O from Na. All the substrates and products of the catalysis 
were prepared according to literature,
2
 isolated and characterized by 
NMR.  
 
                                                 
1
 Benessere, V.; De Roma, A.; Ruffo, F. ChemSusChem 2008, 1, 425 
2
 (a) Leung W.; Cosway S.; Jones R.H.V.; J. Chem. Soc. Perkin Trans.; 2001; 2288, (b) Hansson S.; 
Heumann A.; Rein T.; J. Org. Chem.; 1990; 55; 975 (c) Ji H.; Li L.; Birney D.; J. Am. Chem. Soc.; 
2009; 2-528(d)A. de Roma, F. Ruffo, S. Woodward. Chem Commun (Camb). 2008;(42):5384-6 and 
reference within. 
 
2
 (b)A. de Roma, F. Ruffo, S. Woodward. Chem Commun (Camb). 2008;(42):5384-6 and reference 
within. 
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4.2 PREPARATION OF THE OP INTERMEDIATE  
 
O
O
O
HO
OCH2Ph
HN
O
Ph2P
MeO
1
23
4
56
OP intermediate  
 
A solution of 4 (1.2 g, 2.0 mmol), 2-diphenylphosphinobenzoic acid (2.0 
mmol), 4-dimethylaminopyridine (0.024 g, 0.20 mmol) and 1,3-
dicyclohexylcarbodiimide (0.82 g, 4.0 mmol) in dry  Dichloromethane 
(20 mL) was stirred for 12 h at room temperature under an inert 
atmosphere to afford a suspension. The residue was removed by filtration. 
The resulting solution was evaporated under vacuum, and the residue was 
chromatographed on silica gel (2:1 ethyl acetate/hexane) affording the 
pure product as a white solid (yield: 85%). 
 
Detailed presentation of physical data for 5: [] = +6.7 (c 1, CHCl3); 
selected 1H NMR data: 6.41 (d, 1H, 
3
JNH–H2 = 9.2 Hz, NH), 5.70 (s, 1H, 
OCHO), 5.05 (d, 1H, 
3
JH1–H2 = 4.2 Hz, H1), 4.80 (d, 1H, 
2
Jgem = 11.7 Hz, 
CHHPh), 4.58 (d, 1H, CHHPh), 4.52 (dt, 1H, 
3
JH2–H3 = 10.2 Hz, H2), 4.35 
(dd, 1H, 
3
JH6eq–H5 = 4.2 Hz, 
2
JH6eq–H6ax = 9.0 Hz, H6eq), 4.07 (t, 1H, 
3
JH3–H4 
= 10.2 Hz, H3), 4.02 (dt overlapped, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 9.9 Hz, H5), 
3.97 (s, 3H, OMe), 3.91 (t, 1H, H4), 3.80 (t, 1H, H6ax); selected 13C 
NMR data:  = 170.0, 102.2, 97.4, 82.0, 70.9, 70.0, 69.2, 63.3, 55.5, 55.2. 
Anal. Calcd for C40H38NO7P: C, 71.10; H, 5.67; N, 2.07. Found: C,  
0.89; H, 5.45;  N, 2.11. 
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4.3   GENERAL PROCEDURE FOR THE 
PREPARATION OF THE LIGANDS  
 
 
A solution of OP INTRMEDIATE (1.2 g, 2.0 mmol), the appropriate 
RCO2H acid (2.5 mmol), 4-dimethylaminopyridine (0.24 g, 2.0 mmol) 
and 1,3- dicyclohexylcarbodiimide (0.82 g, 4.0 mmol) in dry 
dichloromethane (10 mL) was stirred for 12 h at room temperature under 
an inert atmosphere affording a suspension. The residue was removed by 
filtration. The resulting solution was evaporated under vacuum, and the 
residue was chromatographed on silica gel (1:2 ethyl acetate/hexane) 
affording the pure product as a white solid (yield: 80– 85%). 
Naplephos s-v where synthesized by adding TEA and the chloride 
derivate of the acid, in refluxing toluene for a day; the work up and the 
yields were the same. 
 
Detailed presentation of physical data for naplephos-b:[] = -7.9 (c 1, 
CHCl3); selected 
1
H NMR data: 6.30 (d, 1H, 
3
JNH–H2 = 9.4 Hz, NH), 5.49 
(s, 1H, OCHO), 5.42 (t, 1H, 
3
JH3–H2 = 
3
JH3–H4 = 9.8 Hz, H3), 4.86 (d, 1H, 
3
JH1–H2 = 3.4 Hz, H1), 4.70 (d, 1H, 
2
Jgem = 11.8 Hz, CHHPh), 4.50 (m, 2H, 
CHHPh and H2), 4.21 (dd,1H, 
3
JH6eq–H5 = 4.0 Hz, 
2
JH6eq–H6ax = 10.0 Hz, 
H6eq), 3.92 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 9.6 Hz, H5), 3.80 (s, 3H, OMe), 
3.76 (t, 1H, H4), 3.75 (t, 1H, H6ax), 2.36 (s, 3H, Me); selected 13C NMR 
data: 260  = 169.0, 166.3, 99.3, 95.1, 76.6, 67.7, 66.3, 60.6, 52.8, 50.2, 
18.7. Anal. Calcd for C42H40NO8P: C, 70.28; H, 5.62; N, 1.95. Found: C, 
70.48; H, 5.59; N, 1.88. 
 
Detailed presentation of physical data for naplephos-c: [] = +7.8 (c 1, 
CHCl3); selected 
1
H NMR data:  = 6.27 (d, 1H, 3JNH–H2 = 9.8 Hz, NH), 
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5.41 (t, 1H, 
3
JH3–H2 = 
3
JH3–H4 = 9.9 Hz, H3), 5.40 (s, 1H, OCHO), 4.87 (d, 
1H, 3JH1–H2 = 3.4 Hz,  H1), 4.68 (d, 1H, 2Jgem = 11.6 Hz, CHHPh), 4.60 
(dt, 1H, H2), 4.47 (d, 1H, CHHPh), 4.19 (dd, 1H, 
3
JH6eq–H5 = 4.4 Hz,  
2
JH6eq–H6ax = 9.8 Hz, H6eq), 3.92 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 10.0 Hz, 
H5), 3.81, (s, 3H, OMe), 3.76 270 (t, 1H, H4), 3.72 (t, 1H, H6ax), 3.65 
(app d, 2H, CH2Ph); selected 13C NMR data:  = 172.3, 168.7, 101.6, 
97.9, 79.8, 70.8, 70.4, 69.0, 63.4, 55.5, 52.9, 41.5. Anal. Calcd for 
C48H44NO8P: C, 72.62; H, 5.59; N, 1.76. Found: C, 72.87; H, 5.50; N, 
1.65.  
 
Detailed presentation of physical data for naplephos-d: [] = +20.8 (c 1, 
CHCl3); selected 1H NMR data: 6.35 (d, 1H, 
3
JNH– H2 = 10.0 Hz, NH), 
5.48 (s, 1H, OCHO), 5.43 (t, 1H, 
3
JH3–H2 = 
3
JH3– H4 = 9.4 Hz, H3), 4.88 (d, 
1H, 
3
JH1–H2 = 4.2 Hz, H1), 4.68 (d, 1H, 
2
Jgem = 11.6 Hz, CHHPh), 4.47 (m, 
2H, CHHPh and H2), 4.18 (dd, 1H, 
3
JH6eq–H5 = 4.2 Hz, 
2
JH6eq–H6ax = 9.2 Hz, 
H6eq), 3.89 (dt, 1H, 280 
3
JH5–H4 = 
3
JH5–H6ax = 9.6 Hz, H5), 3.79 (s, 3H, 
OMe), 3.74 (t, 1H, H4), 3.70 (t, 1H, H6ax), 2.21 (m, 2H, CH2Cy); 
selected 13C NMR data:  = 173.0, 164.4, 99.6, 97.5, 94.0, 75.4, 65.9, 
64.9, 59.4, 51.4, 49.9, 38.3, 30.9, 28.9, 21.9. Anal. Calcd for C48H50NO8P: 
C, 72.07; H, 6.30; N, 1.75. Found: C, 71.69; H, 6.36; N, 1.82.  
 
Detailed presentation of physical data for naplephos-e: [] = _-.2 (c 1, 
CHCl3); selected 1H NMR data:  = 6.47 (d, 1H, 
3
JNH–H2 = 9.6 Hz, NH), 
5.67 (s, 1H, OCHO), 5.59 (t, 1H, 
3
JH3–H2 = 
3
JH3–H4 = 10.0 Hz, H3), 4.98 (d, 
1H, 
3
JH1–H2 = 3.6 Hz, H1), 4.84 (d, 1H, 
2
Jgem = 11.7 Hz, CHHPh), 4.68 (dt, 
1H, H2), 4.63 (d, 1H, CHHPh), 290 4.22 (dd, 1H, 
3
JH6eq–H5 = 4.5 Hz, 
2
JH6eq–H6ax = 9.9 Hz, H6eq), 4.08 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 10.2 Hz, 
H5), 3.96 (s, 3H, OMe), 3.91 (t, 1H, H4), 3.89 (t, 1H, H6ax), 1.29 (s, 9H, 
t-Bu); selected 
13
C NMR data:  = 180.7, 168.4, 101.3, 98.2, 79.6, 70.5, 
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70.0, 69.0, 63.4, 55.5, 52.8, 39.2, 27.3. Anal. Calcd for C45H46NO8P: C, 
71.13; H, 6.10; N, 1.84. Found: C, 71.46; H, 6.29; N, 1.89.  
 
Detailed presentation of physical data for naplephos-f: [] = -16.6 (c 1, 
CHCl3); selected 
1
H NMR data: 6.30 (d, 1H, 
3
JNH– H2 = 9.6 Hz, NH), 5.43 
(t, 1H, 
3
JH3–H2 = 
3
JH3–H4 = 10.0 Hz, H3), 5.33 (s, 1H, OCHO), 4.86 (d, 1H, 
3
JH1–H2 = 3.6 Hz, H1), 4.65 (d, 1H, 300 
2
Jgem = 11.4 Hz, CHHPh), 4.49 (dt, 
1H, H2), 4.45 (d, 1H, CHHPh), 4.15 (dd, 1H, 
3
JH6eq–H5 = 4.4 Hz, 
2
JH6eq–H6ax 
= 9.8 Hz, H6eq), 3.81 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 10.0 Hz, H5), 3.80 (s, 
3H, OMe), 3.72 (t, 1H, H4), 3.66 (t, 1H, H6ax), 3.51 (t, 1H, 
3
JH–H = 7.4 
Hz, CHEtPh), 2.10 (m, 1H, CHHMe), 1.71 (m, 1H, CHHMe), 0.75 (t, 3H, 
3
JH– H = 8.0 Hz, Me); selected 
13
C NMR data:  = 174.6, 168.5, 101.2, 
98.1, 79.4, 70.4, 69.8, 68.9, 63.3, 55.5, 53.5, 52.7, 26.5, 12.2. Anal. Calcd 
for C50H48NO8P: C, 73.07; H, 5.89; N, 1.70. Found: C, 73.22; H, 5.83; N, 
1.61. 
 
Detailed presentation of physical data for naplephos-g: [] = +41.1 (c 1, 
CHCl3); selected 
1
H NMR data: 6.38 (d, 1H, 
3
JNH– H2 = 9.5 Hz, NH), 5.66 
(s, 1H, OCHO), 5.64 (t, 1H, 
3
JH3–H2 = 
3
JH3– H4 = 10.4 Hz, H3), 5.07 (d, 1H, 
3
JH1–H2 = 3.6 Hz, H1), 4.82 (d, 1H, 
2
Jgem = 12.0 Hz, CHHPh), 4.70 (dt, 1H, 
H2), 4.61 (d, 1H, CHHPh), 4.35 (dd, 1H, 
3
JH6eq–H5 = 4.8 Hz, 
2
JH6eq–H6ax = 
10.4 Hz, H6eq), 4.07 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 9.6 Hz, H5), 3.97 (s, 
3H, OMe), 3.94 (t, 1H, H4), 3.92 (t, 1H, H6ax), 3.68 (t, 1H, 
3
JH–H = 7.2 
Hz, CHEtPh), 2.52 (m, 1H, CHHMe), 1.93 (m, 1H, CHHMe), 0.98 (t, 3H, 
3
JH– H = 7.2 Hz, Me); selected 
13
C NMR data:  = 170.6, 164.4, 97.4, 95.2, 
75.5, 66.3, 64.8, 59.3, 51.3, 49.7, 48.8,  2.9, 8.1. Anal. Calcd for 
C50H48NO8P: C, 73.07; H, 5.89; N, 1.70. Found: C, 71.93; H, 320 5.68; N, 
1.81. 
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Detailed presentation of physical data for naplephos-h: [] = -23.0 (c 1, 
CHCl3); selected 1H NMR data:  = 6.34 (d, 1H, 
3
JNH–H2 = 9.8 Hz, NH), 
5.64 (t, 1H, 
3
JH3–H2 = 
3
JH3–H4 = 10.2 Hz, H3), 5.46 (s, 1H, OCHO), 5.16 (s, 
1H, CHPh2), 4.95 (d, 1H, 
3
JH1– H2 = 3.6 Hz, H1), 4.71 (d, 1H, 
2
Jgem = 11.6 
Hz, CHHPh), 4.61 (dt, 1H, H2), 4.48 (d, 1H, CHHPh), 4.30 (dd, 1H, 
3
JH6eq–H5 = 4.6 Hz, 
2
JH6eq– H6ax = 10.2 Hz, H6eq), 3.96 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 9.6 Hz, H5), 3.85 (s, 3H, OMe), 3.75 (t, 1H, H4), 3.75 (t, 1H, 
H6ax); selected 330 13C NMR data:  = 173.3, 168.1, 101.3, 97.9, 79.2, 
70.7, 70.3, 68.8,63.3, 56.9, 55.5, 52.5. Anal. Calcd for C54H48NO8P: C, 
74.55; H, 5.56; N, 1.61. Found: C, 74.10; H, 5.49; N, 1.62. 
 
Detailed presentation of physical data for naplephos-i: [] = - 28.6 (c 1, 
CHCl3); selected 
1
H NMR data:  = 6.25 (d, 1H, 3JNH– H2 = 9.6 Hz, NH), 
5.55 (t, 1H, 
3
JH3–H2 = 
3
JH3–H4 = 9.4 Hz, H3), 5.39 (s, 1H, OCHO), 4.82 (d, 
1H, 
3
JH1–H2 = 3.3 Hz, H1), 4.62 (d, 1H, 
2
Jgem = 11.7 Hz, CHHPh), 4.48 (dt, 
1H, H2), 4.42 (d, 1H, CHHPh), 4.13 (dd, 1H, 
3
JH6eq–H5 = 5.1 Hz, 
2
JH6eq–H6ax 
= 10.2 Hz, H6eq), 3.89 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 10.2 Hz, H5), 3.85 (s, 
3H, OMe), 3.67 (t, 1H, H4), 3.65 (t, 1H, H6ax), 1.85 (s, 3H, Me); selected 
13
C NMR data:  = 175.9, 168.3, 101.7, 98.2, 79.4, 71.0, 70.5, 69.0, 63.4, 
57.0, 57.6, 52.7, 27.1. Anal. Calcd for C55H50NO8P: C, 74.73; H, 5.70; N, 
1.58. Found: C, 72.28; H, 5.81; N, 1.54.  
 
Detailed presentation of physical data for naplephos-j: [] = +14.5 (c 1, 
CHCl3); selected 
1
H NMR data: 6.54 (d, 1H, 
3
JNH– H2 = 9.0 Hz, NH), 5.46 
(t, 1H, 
3
JH3–H2 = 
3
JH3–H4 = 10.2 Hz, H3), 5.44 (s, 1H, OCHO), 4.92 (d, 1H, 
3
JH1–H2 = 3.3 Hz, H1), 4.66 (d, 1H, 
2
Jgem = 11.7 Hz, CHHPh), 4.48 (m, 2H, 
CHHPh and H2), 4.14 (dd, 1H, 
3
JH6eq–H5 = 4.8 Hz, 
2
JH6eq–H6ax = 10.2 Hz, 
H6eq), 3.92 (dt, 1H, 350 
3
JH5–H4 = 
3
JH5–H6ax = 9.6 Hz, H5), 3.74 (s, 3H, 
OMe), 3.70 (t, 1H, H4), 3.65 (t, 1H, H6ax), 2.02 (t, 1H, 
3
JH–H = 6.6 Hz, 
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CHCy2); selected 
13
C NMR data:  = 175.7, 167.5, 101.7, 97.9, 79.5, 
70.3, 69.3, 68.9, 63.2, 57.4, 55.3, 52.9, 36.5. Anal. Calcd for C54H60NO8P: 
C, 73.53; H, 6.86; N, 1.59. Found: C, 73.77; H, 6.76; N, 1.55.  
 
Detailed presentation of physical data for naplephos-k: [] = - 2.0 (c 1, 
CHCl3); selected 
1
H NMR data: 6.38 (d, 1H, 
3
JNH– H2 = 9.6 Hz, NH), 5.68 
(t, 1H, 
3
JH3–H2 = 
3
JH3–H4 = 10.0 Hz, H3), 5.55 (s, 1H, OCHO), 4.91 (d, 1H, 
3
JH1–H2 = 3.6 Hz, H1), 4.71 (d, 1H, 
2
Jgem = 11.8 Hz, CHHPh), 4.66 (dt, 1H, 
H2), 4.48 (d, 1H, CHHPh), 4.22 (dd, 1H, 
3
JH6eq–H5 = 4.2 Hz, 
2
JH6eq–H6ax = 
9.6 Hz, H6eq), 4.10 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 9.6 Hz, H5), 3.85 (t, 1H, 
H4), 3.83 (t, 1H, H6ax), 3.75 (s, 3H, OMe); selected 
13
C NMR data:  = 
168.7, 160.1, 101.4, 97.9, 79.5, 70.7, 70.3, 68.8, 63.3, 55.3, 52.7. Anal. 
Calcd for C47H42NO8P: C, 72.39; H, 5.43; N, 1.80. Found: C, 72.73; H, 
5.48; N, 1.84. 
 
Detailed presentation of physical data for naplephos-l: [] = +12.7 (c 1, 
CHCl3); selected 1H NMR data: 6.26 (d, 1H, 
3
JNH–H2 = 9.2 Hz, NH), 5.47 
(s, 1H, OCHO), 5.41 (t, 1H, 
3
JH3–H2 = 
3
JH3– H4 = 9.8 Hz, H3), 4.84 (d, 1H, 
3
JH1–H2 = 4.2 Hz, H1), 4.66 (d, 1H, 
2
Jgem = 11.6 Hz, CHHPh), 4.60 (dt, 1H, 
H2), 4.47 (d, 1H, CHHPh), 4.18 (dd, 1H, 
3
JH6eq–H5 = 4.4 Hz, 
2
JH6eq–H6ax = 
9.6 Hz, H6eq), 3.91 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 10.0 Hz, H5), 3.80 (s, 
3H, OMe), 3.70 (t, 1H, H4), 3.65 (t, 1H, H6ax); selected 
13
C NMR data:  
= 168.8, 160.2, 101.4, 97.6, 79.1, 71.9, 70.2, 68.7, 63.2, 55.3, 52.3, 28.0. 
Anal. Calcd for C48H39F5NO8P: C, 65.23; H, 4.45; N, 1.58. Found: C, 
65.15; H, 4.44; N, 1.50. 
 
Detailed presentation of physical data for naplephos-m 
selected 
1
H NMR data:  = 6.20 (d, 1H, 3JNH– H2 = 9.6 Hz, NH), 5.52 (t, 
1H, 
3
JH3–H2 = 
3
JH3–H4 = 9.4 Hz, H3), 5.38 (s, 1H, OCHO), 4.83 (d, 1H, 
3
JH1–
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H2 = 3.3 Hz, H1), 4.68 (d, 1H, 
2
Jgem = 11.7 Hz, CHHPh), 4.44 (dt, 1H, 
H2), 4.41 (d, 1H, CHHPh), 4.11 (dd, 1H, 
3
JH6eq–H5 = 5.1 Hz, 
2
JH6eq–H6ax = 
10.2 Hz, H6eq), 3.87 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 10.2 Hz, H5), 3.85 (s, 
3H, OMe), 3.64 (t, 1H, H4), 3.62 (t, 1H, H6ax), 1.85 (s, 6H, Me). 
 
Detailed presentation of physical data for naplephos-n 
selected 
1
H NMR data:  = 6.24 (d, 1H, 3JNH– H2 = 9.6 Hz, NH), 5.51 (t, 
1H, 
3
JH3–H2 = 
3
JH3–H4 = 9.4 Hz, H3), 5.31 (s, 1H, OCHO), 4.87 (d, 1H, 
3
JH1–
H2 = 3.3 Hz, H1), 4.67 (d, 1H, 
2
Jgem = 11.7 Hz, CHHPh), 4.45 (dt, 1H, 
H2), 4.46 (d, 1H, CHHPh), 4.12 (dd, 1H, 
3
JH6eq–H5 = 5.1 Hz, 
2
JH6eq–H6ax = 
10.2 Hz, H6eq), 3.88 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 10.2 Hz, H5), 3.84 (s, 
3H, OMe), 3.64 (t, 1H, H4), 3.61(t, 1H, H6ax), 1.88 (s, 6H, Me); 
 
Detailed presentation of physical data for naplephos-o:  
selected 1H NMR data: 6.4 (d, 1H, NH), 5.75 (t, 1H, H3), 5.45 (s, 1H, 
OCHO), 4.90 (d, 1H, H1), 4.66 (dt, 1H, H2), 4.60 (d, 1H, CHHPh), 4.47 
(d, 1H, CHHPh), 4.20 (dd, 1H, H6eq), 3.90 (dt, 1H, H5), 3.85 (t, 1H, H4), 
3.70(s, 3H, OMe), 3.65 (t, 1H, H6ax);  
selected 
13
C NMR: 168.6, 164.9, 159.9, 149.9, 147.5, 140.5, 140, 113.5, 
101.4, 97.7, 79.1, 71.5, 70.3, 68.7, 63.2, 55.2, 52.5. 
 
Detailed presentation of physical data for naplephos-o’: selected 1H 
NMR data: δ 6.64 (d, 1H, NH-C2, 3JNH-H2 = 9.6Hz), 5.98 (t, 1H, H3, 
3
JH3-
H4 = 19.2Hz, 
3
JH3-H2 = 9.9Hz), 5.70 (s, 1H, H7), 5.55 (d, 1H, H1, 
3
JH1-H2 = 
3.9Hz), 5.27 (dt, 1H, H2), 4.84 (d, 1H, CHHPh, 
2
Jgem = 11.4Hz), 4.60 (d, 
1H, CHHPh), 4.38-4.17 (m, 3H, H5, H6eq, H6ax), 3.99 (t, 1H, H4, 
3
JH4-H5= 
9.9Hz), 3.92 (s, 3H, OCH3).  
selected 
13
C NMR: 169.4, 164.9, 160.2, 150.2, 148.0, 143.4, 142.5, 113.7, 
101.7, 98.5, 79.8, 71.3, 70.9, 69.0, 63.5, 55.5, 52.9. 
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Detailed presentation of physical data for naplephos-p: 
selected 
1
H NMR (300MHz): δ 6.59 (d, 1H, NH-C2, 3JNH-H2 = 9.6Hz), 
5.99 (t, 1H, H3, 
3
JH3-H4 = 19.8Hz, 
3
JH3-H2 = 9.9Hz), 5.69 (s, 1H, H7), 5.12 
(d, 1H, H1, 
3
JH1-H2 = 3.6Hz), 4.96 (dt, 1H, H2), 4.90 (d, 1H, CHHPh, 
2
Jgem 
= 11.7Hz), 4.71 (d, 1H, CHHPh), 4.40 (dd, 1H, H6eq, 
3
JH6eq-H5 = 4.5, 
3
JH6eq-
H6ax = 10.2 Hz), 4.18 (dt, 1H, H5, 
3
JH5-H4= 9.6Hz), 4.12 (t, 1H, H4), 3.97 
(t, 1H, H6ax), 3.91 (s, 3H, OCH3). 
selected 
13
C NMR: 168.2, 165.1, 160.0, 147.8, 121.8, 114.5, 113.9, 101.6, 
98.9, 79.7, 71.6, 71.0, 68.1, 63.2, 55.0, 52.5. 
 
Detailed presentation of physical data for naplephos-p’: 
selected 
1
H NMR (200MHz): δ 6.52 (d, 1H, NH-C2, 3JNH-H2 = 9.0Hz), 
5.86 (t, 1H, H3, 
3
JH3-H2 = 10.1Hz, 
3
JH3-H4 = 19.5Hz), 5.54 (s, 1H, H7), 5.42 
(d, 1H, H1, 
3
JH1-H2 = 3.6Hz), 5.16 (dt, 1H, H2), 4.71 (d, 1H, CHHPh, 
2
Jgem 
= 12.0Hz), 4.42 (d, 1H, CHHPh), 4.24-3.96 (m, 2H, H5, H6eq), 3.82-3.92 
(m, 2H, H4, H6ax), 3.75 (s, 3H, OCH3). 
selected 
13
C NMR: 168.3, 165.1, 160, 149.8, 147.7, 142, 113.5, 101.8, 98, 
72.3, 70.2, 68.4, 67.7, 55.7, 54.2. 
 
Detailed presentation of physical data for naplephos-q 
Selected 
1
H NMR (300MHz): δ 6.58 (d, 1H, NH-C2, 3JNH-H2= 9Hz), 5.55 
(s, 1H, H7), 5.28 (t, 1H, H3, 
3
JH3-H4= 
3
JH3-H2= 10.2Hz), 4.75 (d, 1H, H1, 
3
JH1-H2= 3.6Hz), 4.62 (s, 1H, CHHPh, 
2
Jgem= 11.4Hz), 4.41 (d, 1H, 
CHHPh), 4.35 (dt, 1H, H2), 4.20 (dd, 1H, H6eq, 
3
JH6eq-H5= 4.8Hz, 
2
JgemH6eq-
H6ax= 10.2Hz),  3.90 (dt, 1H, H5, 
3
JH5-H6ax= 
3
JH5-H4= 10.2Hz), 3.83 (s, 3H, 
OCH3),  3.71 (m, 2H, H6ax+4), 2.80 (s, 3H, Me). 
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Detailed presentation of physical data for naplephos-r 
selected 
1
H NMR (200MHz): δ 6.70 (d, 1H, NH-C2, 3JNH-H2= 9.4Hz), 5.50 
(s, 1H, H7), 5.30 (t, 1H, H3, 
3
JH3-H4= 
3
JH3-H2= 10.4Hz), 4.80 (d, 1H, H1, 
3
JH1-H2= 3.6Hz),  4.65 (d, 1H, CHHPh, 
2
Jgem= 11.8Hz), 4.42 (d, 1H, 
CHHPh), 4.35 (dt, 1H, H2), 4.25 (dd, 1H, H6eq, 
3
JH6eq-H5= 4.6Hz, 
2
JgemH6eq-
H6ax= 10.2Hz), 3.94 (dt, 1H, H5, 
3
JH5-H6ax= 
3
JH5-H4= 10.2Hz), 3.78 (s, 3H, 
OCH3), 3.72 (m, 2H, H6ax+4), 3.25 (4H, CH2Me), 1.07 (6H, CH2Me). 
 
 
Detailed presentation of physical data for naplephos-s: 
Selected 
1
H NMR (300MHz): δ 6.56 (d, 1H, NH-C2, 3JNH-H2= 9Hz), 5.49 
(s, 1H, H7), 5.32 (t, 1H, H3, 
3
JH3-H4= 
3
JH3-H2= 10.2Hz), 4.85 (d, 1H, H1, 
3
JH1-H2= 3.6Hz), 4.68 (s, 1H, CHHPh, 
2
Jgem= 11.4Hz), 4.46 (d, 1H, 
CHHPh), 4.39 (dt, 1H, H2), 4.18 (dd, 1H, H6eq, 
3
JH6eq-H5= 4.8Hz, 
2
JgemH6eq-
H6ax= 10.2Hz),  3.93 (dt, 1H, H5, 
3
JH5-H6ax= 
3
JH5-H4= 10.2Hz), 3.80 (s, 3H, 
OCH3),  3.72 (m, 2H, H6ax+4), 2.80 (s, 3H, Me). 
 
Detailed presentation of physical data for naplephos-t: 
selected 
1
H NMR (200MHz): δ 6.72 (d, 1H, NH-C2, 3JNH-H2= 9.4Hz), 5.51 
(s, 1H, H7), 5.35 (t, 1H, H3, 
3
JH3-H4= 
3
JH3-H2= 10.4Hz), 4.89 (d, 1H, H1, 
3
JH1-H2= 3.6Hz),  4.68 (d, 1H, CHHPh, 
2
Jgem= 11.8Hz), 4.47 (d, 1H, 
CHHPh), 4.37 (dt, 1H, H2), 4.20 (dd, 1H, H6eq, 
3
JH6eq-H5= 4.6Hz, 
2
JgemH6eq-
H6ax= 10.2Hz), 3.93 (dt, 1H, H5, 
3
JH5-H6ax= 
3
JH5-H4= 10.2Hz), 3.79 (s, 3H, 
OCH3), 3.71 (m, 2H, H6ax+4), 3.27 (4H, CH2Me), 1.07 (6H, CH2Me). 
 
Detailed presentation of physical data for naplephos-u: 
selected 
1
H NMR (200MHz): δ 7.84 (d, 1H, NH-C2, 3JNH-H2= 9Hz), 5.52 
(s, 1H, H7), 5.40 (t, 1H, H3, 
3
JH3-H4= 
3
JH3-H2= 10.0Hz), 4.93 (d, 1H, H1, 
3
JH1-H2= 3.4Hz),  4.67 (d, 1H, CHHPh, 
2
Jgem= 11.6Hz), 4.45 (d, 1H, 
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CHHPh), 4.38 (dt, 1H, H2), 4.20 (dd, 1H, H6eq, 
3
JH6eq-H5= 4.6Hz, 
2
JgemH6eq-
H6ax= 10Hz), 4.04 (m, 1H, CHi-Pr), 3.96 (m, 1H, H5, 
3
JH5-H6ax= 9.8Hz), 
3.79 (s, 3H, OCH3), 3.72 (m, 2H, H6ax+4), 1.14 (m, 12H, Mei-Pr). 
 
Detailed presentation of physical data for naplephos-v: 
Selected 
1
H NMR (200MHz): δ 6.79 (d, 1H, NH-C2, 3JNH-H2= 8.8Hz), 
5.50 (s, 1H, H7), 5.36 (t, 1H, H3, 
3
JH3-H4= 
3
JH3-H2= 9.6Hz), 4.93 (d, 1H, 
H1, 
3
JH1-H2= 3.4Hz),  4.67 (d, 1H, CHHPh, 
2
Jgem= 11.8Hz), 4.45 (d, 1H, 
CHHPh), 4.38 (m, 1H, H2), 4.20 (dd, 1H, H6eq, 
3
JH6eq-H5= 4.2Hz, 
2
JgemH6eq-
H6ax= 10.2Hz), 3.96 (m, 1H, H5, 
3
JH5-H6ax= 10.2Hz), 3.79 (s, 3H, OCH3), 
3.72 (m, 1H, H6ax+4), 3.35 (m, 6H, NCH2n-Bu), 0.80 (m, 14H, 
CH2CH2CH3n-Bu). 
 
Detailed presentation of physical data for L1: selected 
1
H NMR data: 6.15 
(d, 1H, NH), 5.74 (t, 1H, H3), 4.95 (d, 1H, H1), 4.85 (s, 1H, OCHO), 4.55 
(dt, 1H, H2), 4.50 (d, 1H, CHHPh), 4.15 (d, 1H, CHHPh), 4.05 (dd, 1H, 
H6eq), 3.90 (dt, 1H, H5), 3.85 (t, 1H, H4), 3.70(s, 3H, OMe), 3.60 (t, 1H, 
H6ax); 
 
Detailed presentation of physical data for L2 
selected 1H NMR data:  = 6.08 (d, 1H, 3JNH–H2 = 9.8 Hz, 
NH), 5.77 (t, 1H, 
3
JH3–H2 = 
3
JH3–H4 = 2.5 Hz, H3), 5.56 (s, 1H, 
OCHO), 5.07 (s, 1H, CHPh2), 4.95 (d, 1H, 
3
JH1– H2 = 3.6 Hz, 
H1), 4.71 (d, 1H, 
2
Jgem = 11.6 Hz, CHHPh), 4.61 (dt, 1H, H2), 
4.48 (d, 1H, CHHPh), 4.30 (dd, 1H, 
3
JH6eq–H5 = 4.6 Hz, 
2
JH6eq– 
H6ax = 10.2 Hz, H6eq), 3.96 (dt, 1H, 
3
JH5–H4 = 
3
JH5–H6ax = 9.6 
Hz, H5), 3.85 (s, 3H, OMe), 3.75 (t, 1H, H4), 3.75 (t, 1H, 
H6ax). 
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Synthesis of 1-methyl-2-acetamide-2-deoxy-α-D-glucopiranoside 
                                      
                                         
O
OCH3
NHAcHO
HO
HO
 
                                                     2’’ 
 
A suspension of N-acethyl-D-glucosamine-α-OMe (1’’) (6.0 g, 27 mmol) 
in methanol (140 mL) and Amberlite (10 g) was refluxed for 24 hours. At 
the end of the reaction a brown precipitate is present. This precipitate was 
remover by filtration and the crude solution was cooled at RT, washed 
with Et2O and dryed under vacuum. (yield: 85%). 
 
 
Synthesis of 1-methyl-2-acetamide-3-hydroxy-4,6-O-benzylidene--D-
glucopiranoside 
                                
                                 
Ph
HO
O
O
O OCH3
NHAc  
         3’’ 
 
Compaund 2’’, (7.0 g, 30 mmol), and dry ZnCl2 (7.01 g, 205 mmol), dust, 
were sospende in benzaldehyde (37.6 mL) and stirred for 2 hours at 70 °C. 
600 mL of water were added under stirring and the precipitate was 
filtrated, washed with water and petroleum ether (yield: 52 %). 
 
 
Synthesis of 1-methyl-2-amine-3-hydroxy-4,6-O-benzylidene--D-
glucopiranoside 
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Ph
HO
O
O
O OCH3
NH2  
                                                  4’’ 
 
Compaund 3’’, (3.2 g, 9.9 mmol) was added to a warm solution of  KOH 
(28 g, 500 mmol) in ethanol (63 mL) and refluxed for 24 hours. Water 
was added and entracte 3 times with DCM. The crude product was then 
passed on Na2SO4 and dryed under vacuum. White solid (yield: 72%).  
selected 
1
H NMR (200 MHz) :  = 5.49 (s, 1H, CHPh), 4.62 (d, 1H, H1, 3J 
H1-H2 = 3.4 Hz), 4.24 (dd, 1H, H2, 
3
J H2-H3 = 
3
J H3-H4 = 8.6 Hz) 3.74-3.62 (m, 
2H, H4, H5,  
3
J H4-H5 = 9.6 Hz ) , 3.39 (t, 1H, H3), 3.40 (s, 3H, OCH3), 2.7  
( dd ,1H , NH2C2, 
 3
J NHC2-H2 = 6 Hz) . 
 
 
Synthesis of 5’’ 
             
                                   
O
OCH3
HN
O
HO
PPh2
O
O
Ph
 
                               
 
 
A solution of 4’’ (1.3 g, 4.5  mmol), 2-diphenylphosphinobenzoic acid 
(2.0 mmol), 4-dimethylaminopyridine (0.024 g, 0.20 mmol) and 1,3-
dicyclohexylcarbodiimide (0.82 g, 4.0 mmol) in dry  Dichloromethane 
(20 mL) was stirred for 12 h at room temperature under an inert 
5’’ 
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atmosphere to afford a suspension. The residue was removed by filtration. 
The resulting solution was evaporated under vacuum, and the residue was 
chromatographed on silica gel (2:1 ethyl acetate/hexane) affording the 
pure product as a white solid (yield: 85%). 
selected 
1
H NMR (200 MHz) :  = 6.24 (d, 1H, NH-C2, 3JNH-H2 = 9.2 Hz), 
5.57 (s, 1H, H7) , 4.61 (d, 1H, H1, 
3
J H1-H2 = 3.6 Hz), 4.27 (dd, 1H, H6eq , 
3
J H6eq-H5 = 4 Hz, 
2
J H6eq-H6ax = 9.6 Hz ), 4.36 (dt, 1H, H2), 3.85  (td ,1H,H5,
 
3
J H6ax-H5 = 9.6 Hz), 3.752 (t , 1H, H6ax ), 3.67-3.63 (m, 2H, H3,H4
 3
JH3-H4 
=
3
JH2-H3 = 7.8 Hz), 3.22 (s, 3H, CH3O). 
 
 
Synthesis of L3 
 
                                
O
OCH3
HNO
O
Ph2P
O
O
Ph
Ph
O
Ph
 
 
 
A solution of 5’’ (0.50 g, 8.4 mmol), the Ph2CHCO2H acid (2.5 mmol), 4-
dimethylaminopyridine (0.24 g, 2.0 mmol) and 1,3- 
dicyclohexylcarbodiimide (0.82 g, 4.0 mmol) in dry dichloromethane (10 
mL) was stirred for 12 h at room temperature under an inert atmosphere 
affording a suspension. The residue was removed by filtration. The 
resulting solution was evaporated under vacuum, and the residue was 
chromatographed on silica gel (1:2 ethyl acetate/hexane) affording the 
pure product as a white solid (yield: 80– 85%). 
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Detailed presentation of physical data for L3 
Risonanze selezionate 
1
H NMR (200 MHz) :  = 6.18 (d, 1H, NH-C2, 
3
JNH-H2 = 10 Hz) , 5.52 (t, 1H, H3,
 3
JH3-H4 =
3
JH2-H3 = 9.8 Hz) , 5.46 (s, 1H, 
H7)  5.09 (s, 1H, CHPh2), 4.54 (d, 1H, H1, 
3
J H1-H2 = 3.4 Hz) , 4.48 (dd, 
1H, H2), 4.29 (dd, 1H, H6eq , 
3
J H6eq-H5 = 4 Hz, 
2
J H6eq-H6ax = 9.6 Hz) , 3.89 
(dt, 1H, H5). 
 
Synthesis of Ligands L4: A suspension of picolinic acid (138 mg, 1.12 
mmol) and 1,1_-carbonyldiimidazole (182 mg, 1.12 mmol) in dry 
tetrahydrofuran (2 mL) was heated in a flamedried flask at 50 °C under 
nitrogen for 1 h. Then the appropriate diamine (0.56 mmol) was added, 
and the mixture was stirred at the same temperature for 2 h. The solvent 
was removed  under vacuum and the residue extracted with 
dichloromethane. The organic phase was extracted with water (3.5 mL) 
and the aqueous phases were combined and extracted with 
dichloromethane (2.5 mL). The col lected organic phases were dried with 
sodium sulfate, and the solvent was evaporated to afford ligands L4 (245 
mg, 77%) . Use of the ligands in the catalytic reactions did not require 
any further purification. Recrystallization of L4 from  methanol afforded 
136 mg (43%) of the product. 
 
Detailed presentation of physical data for L4 
Selected 
1
H NMR (400 MHz, CDCl3): δ = 8.53 (d, J = 4.4 Hz, 1 H, H6-
py), 8.52 (d, J = 10.4 Hz, 1 H, NH), 8.38 (d, J = 4.7 Hz, 1 H, H6-py), 8.10 
(d, J = 10.4 Hz, 1 H, NH), 7.97 (d, J = 7.8 Hz, 1 H, H3-py), 7.90 (d, J = 
7.8 Hz, 1 H, H3-py), 7.66–7.62 (m, 2 H, H4-py), 7.36–7.30 (m, 4 H, H5-
py and Ph H), 7.28– 7.16 (m, 8 H, Ph), 5.50 (s, 1 H, OCHO), 4.97 (d, J = 
3.6 Hz, 1 H, H1), 4.81 (q, J = 10.4 Hz, 1 H, H3), 4.77 (d, J = 12.2 Hz, 1 
H, CHHPh), 4.58 (dt, J = 10.4, 3.6 Hz, 1 H, H2), 4.54 (d, J = 12.2 Hz, 
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1 H, CHHPh), 4.22 (dd, J = 10.2, 4.9 Hz, 1 H, H6eq), 4.06 (dt, J = 9.9, 
4.9 Hz, 1 H, H5), 3.86 (dd, J = 10.2, 9.9 Hz, 1 H, H6ax), 3.76 (t, J = 10.3 
Hz, 1 H, H4) ppm.  
Selected 
13
C NMR (100 MHz, CDCl3): 
δ = 165.5, 165.1, 149.9, 149.8, 148.7, 148.3, 137.6 (2 C, overlapped), 
137.4 (2 C, overlapped), 129.3, 128.8, 128.6, 128.4, 128.3, 126.7, 126.5, 
126.4, 122.7, 122.6, 102.2, 97.5, 80.3, 70.2, 69.5, 64.6, 53.4, 50.7. 
 
Synthesis of Ligand L5: A solution of picolinic acid (520 mg, 4.2 
mmol), 4-(dimethylamino)pyridine (48 mg, 0.43 mmol) and 1,3 
dicyclohexylcarbodiimide (890 mg, 4.3 mmol) in dry dichloromethane (7 
mL) was added to a solution benzyl 2-amino-2-deoxy-4,6-O-(4 
methoxybenzylidene)-α-D-glucopyranoside, (2.0 mmol) in the same 
solvent (7 mL). The resulting mixture was stirred at room temperature 
under an inert gas for 12 h to afford a yellow suspension. The precipitate 
was removed by filtration. The resulting yellow solution was concentrated 
under vacuum, and the residue was chromatographed on silica gel (ethyl 
acetate/hexane, 1:5) to afford the pure product as a white solid (yield: 777 
mg, 65%).  
 
Detailed presentation of physical data for L5 
Selected 
1
H NMR (300 MHz, CDCl3, 298 K): δ = 8.60 (d, J = 4.8 Hz, 1 
H, H6-py), 8.55 (d, J = 5.1 Hz, 1 H, H6-py), 8.48 (d, J = 9.9 Hz, 1 H, 
NH), 8.05 (d, J = 7.5 Hz, 1 H, H3-py), 7.95 (d, J = 7.8 Hz, 1 H, H3-py), 
7.71 (t, J = 7.8 Hz, 2 H, H4-py), 7.40–7.10 (m, 9 H, H5-py and Ph H), 
6.80 (d, J = 8.4 Hz, 2 H, Ph), 5.85 (t, J = 9.9 Hz, 1 H, H3), 5.50 (s, 1 H, 
OCHO), 5.01 (d, J = 3.6 Hz, 1 H, H1), 4.73 (m, 2 H, H2, CHHPh), 4.58 
(d, J = 12Hz, 1 H, CHHPh), 4.25 (dd, J = 10.2, 4.5 Hz, 1 H, H6eq), 4.11 
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(dt, J = 10.2, 4.5 Hz, 1 H, H5), 3.96 (t, J = 9.6 Hz, 1 H, H6ax), 3.82 (t, J = 
10.2 Hz, 1 H, H4), 3.70 (s, 3 H, OCH3) ppm.  
Selected 
13
C NMR (75.3 MHz, CDCl3): δ = 164.7, 164.6, 160.3, 150.1, 
149.4, 148.5, 147.8, 137.3, 137.0, 136.8, 129.7, 128.6, 128.4, 128.3, 
127.7, 127.0, 126.5, 125.7, 122.3, 113.8, 101.7, 97.6, 79.6, 71.9, 70.2, 
69.1, 63.5, 55.4, 52.6 ppm. 
 
4.4  GENERAL PROCEDURE FOR THE Pd-AAA 
CATALYTIC REACTION  
 
With the sodium salt of dimethylmalonate: a solution of [Pd(-Cl)- (3-
allyl)]2 (0.0020 g, 0.0050 mmol) and the appropriate naplephos (0.022 
mmol) in 0.5 mL of dry THF was stirred under nitrogen for 0.5 h. A 
solution of substrate ( 0.25 mmol) in 0.5 mL of the same solvent was then 
added. After stirring the resulting light yellow solution for additional 0.5 
h, a solution of the sodium salt of dimethylmalonate (0.116 g, 0.750 
mmol) (and the additive when present) in 4mL of dry THF was added. 
After the required reaction time, the system was quenched by the addition 
of aqueous ammonium chloride. The product was extracted with 
dichloromethane and, after drying over sodium sulphate, the product was 
isolated by column chromatography on silica gel (dichloromethane). 
 
With BSA/dimehylmalonate: a solution of [Pd(-Cl)- (3-allyl)]2 (0.0020 
g, 0.0050 mmol) and the appropriate naplephos (0.022 mmol) in 0.5 mL 
of dry dichloromethane was stirred under nitrogen for 0.5 h. A solution of 
substrate (0.25 mmol) in 0.5 mL of the same solvent was then added. 
After stirring the resulting light yellow solution for additional 0.5 h, a 
solution of dimethylmalonate (0.0997 g, 0.750 mmol), BSA (0.152 g, 
0.750 mmol) and a pinch of the acetate salt in 2 mL of dry 
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dichloromethane was added. After the required reaction time, the system 
was quenched by the addition of aqueous ammonium chloride. The 
organic phase was dried over sodium sulphate, and the product was 
isolated by column chromatography on silica gel (dichloromethane). 
 
4.5  GENERAL PROCEDURE FOR THE Mo-AAA 
CATALYTIC REACTION PROMOTED BY µW 
 
Two different stock solutions were prepared: solution N, containing the 
nucleophile, was prepared by adding dimethyl malonate (880 μL, 7.7 
mmol) to a suspension of 60% NaH in mineral oil in tetrahydrofuran (10 
mL), and solution S, containing the substrate, was prepared by dissolving 
the allylic carbonate (4 or 5) (7.1 mmol) in THF (10 mL). Then the 
appropriate ligand (0.034 mmol) and Mo(CO)6 (6.9 mg, 0.026 mmol) 
were transferred to a flame-dried SmithProcessVialTM. Solution N (1 
mL), solution S, and BSA 311 (208 μL) were added in this order, and the 
suspension was heated in the microwave cavity at 160 °C for the desired 
time. The brown solution obtained was diluted with Et2O to a total 
volume of 10 mL, resulting in a dark precipitate. A sample of the solution 
was filtered through silica gel and analysed by 1H NMR spectroscopy and 
GC-MS to determine the conversion and the regioselectivity. 
The crude product was then purified either by bulb-tobulb distillation or 
by chromatography on silia gel (eluent: petroleum ether/DCM, 1:1). The 
ee was determined by HPLC using a Daicel OD-H (0.46 cm i.d. _ 25 cm) 
column. The structures of the products were confirmed by comparison 
with published spectroscopic data and GC-MS analyses.
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